increas
number
xenobiot
associ
alter
hematopoiet
system
alter
encompass
varieti
direct
indirect
effect
mani
associ
intend
pharmacolog
compound
may
also
relat
offtarget
effect
alter
hematopoiet
system
commonli
reflect
chang
peripher
blood
compon
blood
compon
includ
leukocyt
erythrocyt
platelet
leukocyt
subtyp
human
common
laboratori
speci
includ
neutrophil
lymphocyt
monocyt
eosinophil
basophil
count
erythrocyt
compon
includ
total
erythrocyt
reticulocyt
count
complet
blood
count
cbc
standard
method
analyz
blood
leukocyt
erythrocyt
platelet
compon
absolut
concentr
cell
ml
convent
refer
absolut
count
nonclin
toxic
studi
use
evalu
interpret
chang
blood
compon
rel
percentag
account
total
number
cell
present
may
mislead
interpret
xenobioticrel
alter
blood
compon
made
consider
inher
biolog
variat
cbc
endpoint
observ
common
laboratori
speci
understand
variou
mechan
underli
increas
decreas
blood
compon
count
consider
overlap
mechan
blood
cell
alter
natur
occur
xenobioticinduc
chang
focu
articl
review
commonli
observ
alter
blood
leukocyt
erythrocyt
platelet
compon
common
pattern
alter
blood
leukocyt
compon
summar
tabl
product
neutrophil
granulopoiesi
occur
predominantli
bone
marrow
although
extramedullari
hematopoiesi
may
contribut
particularli
rat
mice
increas
tissu
demand
granulocyt
bone
marrow
diseas
present
tabl
classic
pattern
alter
blood
leukocyt
compon
inflammatori
pattern
acut
chronic
may
slightli
increas
case
b
due
low
eosinophil
basophil
count
health
decreas
may
difficult
identifi
c
morpholog
chang
indic
rapid
neutropoiesi
bodi
cytoplasm
vacuol
cytoplasm
basophilia
may
observ
stimul
granulocytemacrophag
colonystimul
factor
gmcsf
promot
differenti
common
myeloid
progenitor
cell
granulocytemonocyt
progenitor
cell
subsequ
stimul
granulocyt
colonystimul
factor
gcsf
promot
differenti
prolifer
matur
granulocyt
myeloblast
matur
segment
neutrophil
radin
wellman
granulocyt
pool
bone
marrow
divid
prolifer
mitot
matur
postmitot
pool
prolifer
pool
encompass
immatur
myeloid
precursor
myeloblast
promyelocyt
myelocyt
matur
pool
includ
later
stage
metamyelocyt
band
neutrophil
matur
segment
neutrophil
matur
segment
neutrophil
popul
within
matur
pool
also
consid
bone
marrow
storag
pool
act
reserv
store
neutrophil
replenish
blood
store
follow
normal
turnov
quickli
mobil
blood
time
increas
tissu
demand
health
mammalian
blood
neutrophil
matur
segment
neutrophil
distribut
two
pool
within
blood
vessel
circul
pool
margin
pool
circul
pool
neutrophil
flow
freeli
vessel
lumen
sampl
blood
collect
margin
pool
neutrophil
contact
endotheli
cell
temporarili
adher
roll
along
vessel
wall
neutrophil
may
shift
circul
margin
pool
lifespan
neutrophil
circul
short
approxim
h
halflif
blood
ultim
neutrophil
migrat
tissu
surviv
day
smith
neutrophil
part
innat
immun
system
primarili
function
phagocyt
remov
destroy
invad
pathogen
also
secret
proinflammatori
chemotact
mediat
enhanc
respons
innat
adapt
immun
system
blood
neutrophil
typic
numer
leukocyt
human
rhesu
monkey
african
green
monkey
dog
howev
mani
new
world
monkey
tend
lymphocyt
count
greater
neutrophil
count
provench
bollig
et
al
cynomolgu
monkey
tend
initi
predominantli
lymphocyt
circul
young
shift
predominantli
neutrophil
matur
sugimoto
et
al
neutrophil
count
lower
lymphocyt
count
rat
mice
blood
neutrophil
count
may
increas
decreas
depend
stimulu
insult
clinic
increas
neutrophil
count
expect
valu
health
usual
convey
refer
interv
may
refer
neutrophilia
granulocytosi
decreas
neutrophil
count
may
call
neutropenia
granulocytopenia
sever
agranulocytosi
howev
nonclin
toxicolog
studi
convent
use
clinic
terminolog
describ
alter
caus
test
articl
refer
chang
increas
decreas
neutrophil
count
standard
nonclin
toxicolog
studi
terminolog
use
throughout
articl
howev
clinic
term
also
provid
refer
increas
neutrophil
count
neutrophilia
granulocytosi
catecholamineinduc
acut
transient
increas
typic
h
neutrophil
count
mild
typic
increas
twofold
less
occur
respons
endogen
catecholamin
stimul
eg
epinephrin
accompani
increas
blood
leukocyt
count
physiolog
leukocytosi
increas
circul
catecholamin
commonli
associ
excit
fear
exercis
time
refer
acut
stress
increas
neutrophil
count
secondari
catecholamin
stimul
mostli
attribut
shift
neutrophil
margin
pool
circul
pool
result
increas
number
freeli
flow
neutrophil
captur
blood
sampl
may
occur
decreas
express
leukocyt
adhes
molecul
potenti
increas
blood
flow
shear
forc
foster
et
al
benschop
et
al
stockham
scott
everd
et
al
splenic
contract
result
redistribut
sequest
neutrophil
circul
also
contribut
mechan
exogen
catecholamin
adrenerg
agent
caus
increas
blood
neutrophil
count
describ
endogen
catecholamin
stimul
glucocorticoidinduc
pattern
glucocorticoidrel
alter
leukocyt
count
commonli
refer
stress
leukogram
predomin
endogen
steroid
cortison
speci
corticosteron
rat
classic
endogen
steroid
caus
increas
neutrophil
count
accompani
decreas
lymphocyt
count
increas
monocyt
count
decreas
eosinophil
count
howev
effect
may
variabl
depend
speci
increas
neutrophil
count
may
less
promin
absent
rat
mice
interpret
stress
endogen
glucocorticoid
effect
nonclin
toxic
studi
made
conserv
use
weight
evid
approach
also
note
hyperadrenocortic
cush
syndrom
hypercortisol
associ
excess
product
endogen
glucocorticoid
also
caus
increas
blood
neutrophil
count
glucocorticoidmedi
mechan
glucocorticoid
increas
blood
neutrophil
count
sever
mechan
downregul
neutrophil
express
adhes
molecul
lead
shift
margin
circul
pool
prolong
neutrophil
lifespan
circul
due
decreas
tissu
emigr
stockham
scott
neutrophil
halflif
may
also
prolong
due
decreas
apoptosi
cox
increas
neutrophil
lifespan
may
associ
hypersegment
neutrophil
nuclei
observ
blood
smear
evalu
glucocorticoid
also
increas
releas
segment
occasion
band
neutrophil
bone
marrow
storag
pool
although
mechan
contribut
neutrophilia
lesser
degre
shift
circul
pool
stockham
scott
nakagawa
et
al
bone
marrow
expans
stage
myeloid
cell
may
also
increas
glucocorticoid
stimul
trottier
et
al
administr
exogen
glucocorticoid
prednisolon
dexamethason
result
similar
effect
blood
leukocyt
count
inflamm
inflamm
one
common
caus
increas
blood
neutrophil
count
inflamm
typic
character
acut
chronic
although
term
often
use
inconsist
across
disciplin
may
refer
either
durat
inflamm
type
reaction
inflammatori
respons
latter
definit
use
alter
blood
leukocyt
count
acut
inflammatori
stimul
result
tissu
insult
invad
pathogen
caus
releas
proinflammatori
mediat
proinflammatori
mediat
stimul
acut
inflammatori
neutrophilia
includ
tnfa
dinarello
kolackzowska
kube
chang
caus
rapid
initi
releas
bone
marrow
storag
pool
circul
gener
occur
within
h
increas
neutrophil
count
observ
bone
marrow
releas
exce
emigr
neutrophil
site
inflammatori
insult
persist
inflammatori
stimulu
bone
marrow
storag
pool
becom
deplet
immatur
neutrophil
stage
releas
circul
presenc
immatur
neutrophil
blood
call
left
shift
immatur
neutrophil
commonli
band
neutrophil
suffici
stimulu
result
releas
lower
number
immatur
stage
includ
metamyelocyt
myelocyt
even
earlier
stage
left
shift
may
categor
degen
indic
greater
number
immatur
neutrophil
matur
neutrophil
regen
matur
neutrophil
present
greater
number
immatur
neutrophil
degen
left
shift
typic
observ
face
decreas
lownorm
blood
neutrophil
count
tissu
demand
exce
bone
marrow
neutrophil
product
regen
left
shift
tend
occur
increas
blood
neutrophil
count
bone
marrow
product
start
meet
tissu
demand
bone
marrow
neutrophil
product
increas
inflammatori
stimulu
deplet
neutrophil
storag
pool
recruit
immatur
cell
circul
process
prolifer
matur
myelocyt
stage
releas
matur
segment
neutrophil
bone
marrow
take
approxim
day
health
although
transit
time
decreas
day
acut
inflammatori
stimulu
harvey
stockham
scott
due
acceler
granulopoiesi
morpholog
chang
may
occur
cytoplasm
neutrophil
chang
includ
bodi
remnant
rough
endoplasm
reticulum
contain
rna
foami
cytoplasm
vacuol
increas
cytoplasm
basophilia
evid
asynchron
cytoplasm
nuclear
matur
eg
larg
neutrophil
lobe
immatur
nuclear
chromatin
filament
segment
presenc
primari
granul
matur
stage
chang
often
refer
toxic
chang
accur
cellular
morpholog
alter
consid
indic
rapidacceler
neutrophil
product
caus
acut
inflamm
mani
vari
bacteri
fungal
infect
commonli
associ
increas
neutrophil
count
tuberculosi
associ
increas
neutrophil
count
human
macaqu
commonli
use
nonclin
toxicolog
studi
low
et
al
magden
et
al
macaqu
commonli
use
nonclin
toxicolog
studi
shigellosi
may
caus
neutrophilia
without
left
shift
even
absenc
clinic
sign
diarrhea
magden
et
al
macaqu
may
also
increas
neutrophil
count
enter
infect
yersinia
speci
respiratori
tract
infect
streptococcu
pneumonia
klebsiella
pneumonia
magden
et
al
increas
neutrophil
count
also
observ
direct
respons
viral
infect
secondari
viralinduc
tissu
damag
tissu
damag
trauma
paraneoplast
effect
inflammatori
stimulu
persist
long
enough
result
granulocyt
hyperplasia
bone
marrow
least
partial
replenish
neutrophil
storag
pool
increas
blood
neutrophil
count
character
diminish
left
shift
switch
predomin
matur
segment
neutrophil
circul
also
insult
effect
resolv
inflammatori
respons
tissu
demand
neutrophil
may
decreas
result
releas
fewer
immatur
stage
appear
chronic
inflammatori
pattern
nonclin
toxicolog
studi
certain
procedurerel
effect
longterm
catheter
may
caus
inflammatori
leukogram
hall
case
leukemoid
respons
extrem
neutrophilia
may
occur
leukemoid
respons
character
persist
leukocytosi
cell
ml
typic
due
mark
neutrophilia
left
shift
remain
orderli
may
may
morpholog
chang
indic
rapid
granulopoiesi
schultz
sakka
et
al
extrem
neutrophilia
typic
cell
ml
evid
left
shift
term
leukemoid
reaction
extrem
neutrophilia
appropri
appli
retrospect
possibl
hematopoiet
neoplasia
exclud
differenti
leukemoid
respons
extrem
neutrophilia
chronic
myelogen
leukemia
chronic
neutrophil
leukemia
includ
cbc
blood
smear
bone
marrow
evalu
speci
may
also
includ
leukocyt
alkalin
phosphatas
activ
immunophenotyp
cytogenet
analysi
eg
evalu
bcrabl
transloc
serum
gcsf
clonal
evalu
human
schultz
sakka
et
al
leukemoid
reaction
associ
carcinoma
variou
origin
includ
renal
pulmonari
carcinoma
hodgkin
lymphoma
melanoma
sarcoma
may
attribut
aberr
product
proinflammatori
mediat
neoplasm
gcsf
gmcsf
sakka
et
al
leukemoid
reaction
also
report
rat
affect
larg
granular
cell
leukemia
car
et
al
howev
leukemoid
reaction
may
also
associ
infecti
process
includ
dissemin
tuberculosi
clostridium
difficil
coliti
sever
shigellosi
sakka
et
al
chronic
local
suppur
lesion
pyometra
pleuriti
intern
abscess
schultz
stockham
scott
leukemoid
reaction
may
also
seen
secondari
sever
hemorrhag
immunemedi
hemolyt
anemia
schultz
sakka
et
al
inherit
leukocyt
adhes
defici
increas
neutrophil
count
associ
defici
leukocyt
adhes
molecul
may
manifest
leukemoid
respons
extrem
neutrophilia
adhes
molecul
express
neutrophil
respons
neutrophil
margin
roll
along
vessel
wall
emigr
tissu
lselectin
mediat
lowaffin
initi
bind
leukocyt
endotheli
cell
integrin
includ
mediat
firm
adhes
endotheli
cell
ligand
extracellular
matrix
muller
neutrophil
constitut
express
defici
integrin
leukocyt
adhes
defici
lad
type
result
failur
neutrophil
emigr
tissu
may
result
sever
recurr
bacteri
infect
arnaout
lad
type
due
inherit
disord
fucos
metabol
result
lack
selectin
ligand
express
neutrophil
therefor
result
immunodefici
failur
selectinmedi
neutrophil
roll
along
vessel
wall
marquardt
et
al
leukocyt
adhes
defici
report
human
dog
mice
holstein
cattl
arnaout
marquardt
et
al
gu
et
al
neoplasia
neoplasm
involv
hematopoiet
cell
natur
occur
rel
low
frequenc
gener
neoplast
process
may
observ
background
find
rat
mice
longer
toxic
studi
eg
carcinogen
studi
uncommon
nonrod
speci
toxic
studi
increas
neutrophil
count
may
observ
part
neoplast
process
chronic
myeloid
leukemia
cml
chronic
neutrophil
leukemia
cnl
leukocytosi
cml
cell
ml
increas
stage
neutrophil
myeloid
cell
blood
typic
accompani
increas
monocyt
count
eosinophil
count
basophil
count
platelet
count
possibl
increas
nucleat
erythroid
precursor
sawyer
contrast
leukemoid
respons
left
shift
associ
cml
tend
less
orderli
greater
number
earlier
stage
myeloid
cell
circul
along
band
segment
neutrophil
morpholog
featur
indic
dysplasia
may
seen
cytoplasm
featur
indic
rapid
granulopoiesi
may
observ
neutrophil
associ
cml
bone
marrow
find
includ
hypercellular
increas
myeloid
erythroid
ratio
myeloblast
promyelocyt
make
cell
sawyer
human
case
chronic
myeloid
leukemia
associ
transloc
chromosom
philadelphia
chromosom
result
constitut
activ
bcrabl
tyrosin
kinas
oncogen
induc
leukemia
sawyer
compar
bcrabl
transloc
observ
dog
breen
modiano
cruz
cardona
et
al
culver
et
al
transgen
knockin
mous
model
bcrabl
translocationinduc
cml
util
research
ren
chronic
neutrophil
leukemia
also
character
blood
leukocyt
count
cell
ml
compos
segment
band
neutrophil
uppal
gong
neutrophil
may
may
cytoplasm
chang
indic
rapid
neutropoiesi
unlik
cml
increas
neutrophil
count
associ
cnl
typic
associ
morpholog
featur
dysplasia
presenc
earlier
stage
myeloid
cell
ie
myeloblast
promyelocyt
myelocyt
metamyelocyt
increas
monocyt
eosinophil
basophil
count
increas
nucleat
erythroid
precursor
uppal
gong
bone
marrow
chang
associ
cnl
includ
hypercellular
increas
myeloid
erythroid
ratio
myelocyt
band
neutrophil
stage
increas
without
appar
increas
myeloblast
promyelocyt
uppal
gong
differenti
cnl
leukemoid
reaction
extrem
neutrophilia
may
difficult
affect
patient
care
evalu
exclud
caus
neutrophilia
associ
hematopoiet
malign
xenobioticinduc
numer
xenobiot
increas
blood
neutrophil
count
typic
similar
mechan
describ
natur
occur
increas
neutrophil
count
sever
exampl
compound
describ
later
administr
exogen
catecholamin
epinephrin
adrenerg
agonist
similar
effect
mediat
endogen
catecholamin
shift
neutrophil
margin
circul
pool
respons
increas
blood
neutrophil
count
potenti
alter
adhes
molecul
express
hemodynam
forc
leukocyt
subtyp
differ
receptor
modul
adrenerg
effect
neutrophil
appear
primarili
affect
aadrenerg
receptor
benschop
et
al
exogen
glucocorticoid
prednisolon
dexamethason
betamethason
mediat
increas
neutrophil
count
similar
mechan
endogen
glucocorticoid
brief
increas
neutrophil
count
due
shift
neutrophil
margin
circul
pool
releas
neutrophil
bone
marrow
storag
pool
expans
granulopoiesi
bone
marrow
dose
durat
glucocorticoid
therapi
may
alter
proport
contribut
effect
increas
neutrophil
count
heparininduc
increas
neutrophil
count
report
small
percentag
patient
receiv
heparin
therapi
mechan
like
multifactori
heparin
may
caus
shift
neutrophil
circul
pool
margin
pool
due
decreas
express
selectin
zhang
et
al
heparinrel
releas
chemokin
constitut
express
bone
marrow
stromal
cell
play
role
bone
marrow
neutrophil
retent
leukocyt
traffick
may
alter
bone
marrow
circul
gradient
promot
releas
neutrophil
bone
marrow
storag
pool
contribut
increas
circul
neutrophil
count
zhang
et
al
administr
gcsf
gmcsf
may
use
rescu
therapi
follow
chemotherapi
caus
neutropenia
compromis
immun
system
abil
respond
infecti
agent
goal
treatment
chemotherapi
patient
increas
blood
neutrophil
count
normal
level
achiev
increas
neutrophil
count
repeat
high
dose
administr
gcsf
gmcsfrelat
compound
healthi
laboratori
anim
result
markedli
increas
neutrophil
count
typic
chang
associ
left
shift
cytoplasm
chang
indic
rapid
neutropoiesi
dysplast
chang
may
also
occur
commonli
recogn
presenc
unusu
larg
neutrophil
hyperseg
neutrophil
circul
sever
xenobiot
appear
induc
increas
neutrophil
count
stimul
increas
endogen
gcsf
inflammatori
stimulu
earli
cours
treatment
clozapin
antipsychot
agent
rat
shown
spike
gcsf
concomit
increas
bone
marrow
granulopoiesi
releas
less
matur
neutrophil
circul
lobach
uetrecht
howev
xenobiot
may
directli
caus
inflammatori
stimulu
increas
endogen
proinflammatori
stimuli
gcsf
result
increas
neutrophil
count
exampl
lithium
use
treatment
bipolar
disord
combin
antidepress
also
appear
caus
increas
neutrophil
count
due
increas
gcsf
focosi
et
al
xenobioticinduc
increas
neutrophil
count
may
observ
conjunct
sever
cutan
drug
reaction
result
inflammatori
stimuli
acut
gener
exanthemat
pustulosi
drugrel
skin
reaction
gener
occur
within
day
drug
administr
resolv
spontan
within
day
roujeau
increas
eosinophil
count
may
may
observ
along
increas
neutrophil
count
xenobiot
classic
associ
syndrom
includ
diltiazem
antibiot
aminopenicillin
pristinamycin
roujeau
acut
febril
dermatosi
sweet
syndrom
also
associ
elev
circul
neutrophil
count
druginduc
form
condit
variabl
link
varieti
compound
includ
gmcsf
trimethoprimsulfamethoxazol
minocyclin
celecoxib
furosemid
azathioprin
rochet
et
al
saavedra
et
al
decreas
neutrophil
count
neutropenia
granulocytopenia
agranulocytosi
overwhelm
sever
acut
inflamm
although
inflamm
often
caus
increas
neutrophil
count
overwhelm
sever
acut
inflammatori
stimulu
may
result
decreas
neutrophil
count
inflammatori
stimulu
sometim
also
refer
peracut
inflamm
commonli
observ
bacteri
sepsi
decreas
neutrophil
count
result
emigr
tissu
exceed
bone
marrow
capac
releas
neutrophil
proinflammatori
mediat
chemoattract
stimul
increas
neutrophil
margin
firm
adhes
endotheli
cell
emigr
tissu
shorten
neutrophil
circul
halfliv
deplet
circul
neutrophil
pool
neutrophil
releas
bone
marrow
storag
pool
deplet
recruit
immatur
neutrophil
circul
result
left
shift
number
immatur
form
exce
number
matur
segment
neutrophil
degen
left
shift
stimulu
persist
long
enough
granulocyt
hyperplasia
bone
marrow
occur
number
circul
neutrophil
increas
shift
toward
greater
number
matur
immatur
neutrophil
endotoxemia
decreas
neutrophil
count
may
observ
result
gramneg
bacteri
infect
releas
endotoxin
endotoxemia
demonstr
increas
express
integrin
decreas
express
lselectin
neutrophil
wagner
roth
mediat
shift
circul
margin
pool
firm
adhes
endotheli
cell
evid
upregul
contribut
neutrophil
vascular
sequestr
lung
liver
also
evid
mechan
cytoskelet
chang
alter
neutrophil
deform
caus
initi
vascular
sequestr
neutrophil
consist
observ
endotoxemia
wagner
roth
decreas
neutrophil
count
associ
endotoxemia
tend
rapid
transient
detect
decreas
neutrophil
count
depend
time
blood
collect
relat
endotoxem
concurr
subsequ
proinflammatori
stimuli
decreas
neutrophil
count
may
associ
viral
infect
although
viralspecif
mechan
vari
decreas
neutrophil
count
associ
parvoviru
like
repres
primari
effect
due
infect
caus
death
rapidli
divid
hematopoiet
precursor
bone
marrow
well
secondari
increas
tissu
demand
diseas
loss
integr
intestin
tract
decreas
neutrophil
count
associ
human
immunodefici
viru
hiv
infecti
hepat
infecti
mononucleosi
peopl
also
associ
decreas
ineffect
neutrophil
product
due
infect
hematopoiet
precursor
dale
welt
lima
et
al
measl
dengu
viru
decreas
neutrophil
count
observ
endotheli
cell
alter
lead
increas
adhes
neutrophil
therefor
shift
circul
margin
pool
dale
welt
decreas
blood
neutrophil
count
may
also
result
decreas
neutrophil
product
acquir
viral
immunodefici
immunodefici
syndrom
decreas
neutrophil
count
report
infect
hiv
peopl
simian
immunodefici
viru
siv
simian
betaretroviru
monkey
felin
immunodefici
viru
fiv
felin
leukemia
viru
felv
cat
levin
et
al
israel
plaisanc
magden
et
al
gill
et
al
gleich
hartmann
immunemedi
primari
idiopath
immunemedi
destruct
matur
neutrophil
neutrophil
precursor
result
decreas
neutrophil
count
report
human
laboratori
speci
antineutrophil
antibodi
commonli
igg
less
commonli
igm
class
opson
neutrophil
membran
may
lead
leukoagglutin
neutrophil
sequestr
site
includ
spleen
liver
lymph
node
phagocytosi
macrophag
antineutrophil
antibodi
may
caus
direct
cytotox
either
complementmedi
complementindepend
mechan
chicker
prass
human
immunemedi
neutrophil
destruct
due
antibodydepend
lymphocyt
cytotox
report
logu
et
al
system
lupu
erythematosu
sle
autoimmun
condit
associ
decreas
neutrophil
count
decreas
blood
neutrophil
count
appear
rel
common
sle
usual
observ
conjunct
manifest
sle
arthriti
skin
lesion
neurolog
disord
stone
associ
decreas
neutrophil
count
presenc
autoantibodi
sle
hsieh
et
al
budman
steinberg
lead
destruct
death
neutrophil
howev
slerel
antigcsf
autoantibodi
also
observ
caus
decreas
blood
neutrophil
count
due
decreas
product
rather
addit
direct
neutrophil
destruct
death
hellmich
et
al
case
primari
idiopath
aplast
anemia
result
underli
immunemedi
destruct
uncommit
earli
lineagecommit
hematopoiet
stem
cell
young
et
al
aplast
anemia
character
pancytopenia
mark
decreas
blood
compon
count
hematopoiet
cell
hypocellular
bone
marrow
although
commonli
associ
immunemedi
destruct
hematopoiet
precursor
mark
deplet
bone
marrow
hematopoiet
cell
aplast
anemia
may
also
occur
sever
nutrit
defici
associ
anorexia
nervosa
abella
et
al
feed
restrict
rat
moriyama
et
al
levin
et
al
cobalamin
b
folat
b
defici
cobalamin
folat
caus
disrupt
dna
synthesi
result
megaloblast
hematopoiesi
commonli
associ
megaloblast
anemia
occasion
decreas
neutrophil
count
andor
pancytopenia
dale
welt
green
cobalamin
folat
defici
may
due
malnutrit
malabsorpt
gastrointestin
diseas
dysfunct
genet
defici
transport
protein
intrins
factor
transcobalamin
rfactor
cobalamin
receptor
intestin
absorpt
cubam
receptor
metabol
enzym
methylenetetrahydrofol
reductas
folat
fowler
whitehead
montagl
tauro
green
quadro
megaloblast
hematopoiesi
asynchron
cytoplasm
nuclear
matur
may
result
giant
granulocyt
irregular
nuclear
chromatin
pattern
giant
metamyelocyt
green
hyperseg
neutrophil
thompson
et
al
condit
often
manag
supplement
defici
vitamin
differenti
cobalamin
folat
deficiencyinduc
decreas
blood
neutrophil
count
copper
defici
similar
clinic
manifest
lazarchick
myelophthisi
myelofibrosi
myelonecrosi
condit
effac
bone
marrow
caviti
displac
hematopoiet
cell
myelophthisi
may
result
decreas
product
hematopoiet
cell
line
includ
neutrophil
myeloprolif
syndrom
tefferi
vardiman
mani
leukem
diseas
talcott
et
al
lami
loughran
lymphoprolif
neoplasia
schultz
metastat
carcinoma
makoni
laber
caus
suffici
bone
marrow
overcrowd
decreas
product
neutrophil
fungal
infect
result
granulomat
inflamm
bone
marrow
observ
dissemin
histoplasmosi
may
also
result
decreas
neutrophil
product
disrupt
bone
marrow
caviti
hematopoiet
stem
cell
myelofibrosi
myelonecrosi
may
also
associ
decreas
blood
neutrophil
count
stockham
scott
xenobioticinduc
xenobioticinduc
decreas
neutrophil
count
may
caus
immunemedi
nonimmunemedi
mechan
incid
event
tend
low
implic
xenobiot
except
chemotherapeut
agent
exampl
immunemedi
nonimmunemedi
mechan
describ
later
similar
primari
immunemedi
decreas
neutrophil
count
xenobioticinduc
immunemedi
decreas
neutrophil
count
commonli
associ
igg
igm
antineutrophil
antibodi
although
drug
may
induc
salama
et
al
decreas
neutrophil
count
mechan
tend
occur
rapidli
within
hour
day
exposur
schwartzberg
xenobiot
mediat
effect
act
hapten
induc
antibodi
respons
target
antigen
form
xenobioticneutrophil
combin
drug
report
act
hapten
includ
penicillin
goldbas
compound
aminopyrin
propylthiouracil
salama
et
al
murphi
et
al
xenobiot
induc
neutrophil
destruct
drugdepend
manner
discontinu
treatment
gener
result
resolut
blood
neutrophil
count
within
day
schwartzberg
xenobiot
includ
propylthiouracil
quinidin
sulfat
caus
format
immun
complex
subsequ
bind
destroy
neutrophil
even
xenobiot
longer
present
schwartzberg
bhatt
saleem
eisner
et
al
addit
xenobiot
propylthiouracil
may
also
caus
format
antineutrophil
antibodi
result
complementmedi
neutrophil
destruct
akamizu
et
al
similar
idiopath
aplast
anemia
xenobioticinduc
aplast
anemia
commonli
associ
immunemedi
destruct
uncommit
earli
hematopoiet
stem
cell
although
direct
cytotox
chemotherapeut
agent
may
also
lead
aplast
anemia
sever
xenobiot
includ
chloramphenicol
anticonvuls
phenytoin
carbamazepin
goldbas
compound
phenylbutazon
associ
aplast
anemia
bloom
brandt
numer
xenobiot
also
link
sle
decreas
blood
neutrophil
count
case
xenobioticinduc
sle
decreas
neutrophil
count
reflect
product
autoantibodi
subsequ
neutrophil
destruct
similar
nonxenobioticinduc
sle
xenobiot
associ
sle
includ
anticonvuls
phenothiazin
chlorpromazin
valproat
antibiot
penicillin
streptomycin
tetracyclin
griseofulvin
sulphonamid
miscellan
xenobiot
captopril
phenylbutazon
lovastatin
stone
mutasim
adam
laboratori
speci
use
nonclin
toxicolog
studi
transient
xenobioticinduc
decreas
blood
neutrophil
count
associ
anaphylactoid
reaction
term
complement
activationrel
pseudoallergi
carpa
nonhypersensit
reaction
mediat
instead
activ
complement
cascad
lead
product
anaphylatoxin
carpa
typic
occur
first
dose
xenobiot
decreas
sever
resolut
follow
addit
dose
xenobiot
implic
carpa
reaction
includ
radiocontrast
media
drugcarri
liposom
lipid
complex
solvent
amphiphil
emulsifi
cremophor
el
szebeni
nonimmunemedi
decreas
neutrophil
count
may
observ
bone
marrow
suppress
associ
mani
xenobiot
particularli
chemotherapeut
agent
chemotherapeuticrel
decreas
neutrophil
count
often
result
direct
cytotox
suppress
prolifer
rapidli
divid
granulocyt
precursor
bone
marrow
exampl
chemotherapeut
class
associ
decreas
blood
neutrophil
count
includ
agent
caus
direct
dna
damag
platinumcontain
agent
eg
cisplatin
carboplatin
classic
alkyl
agent
eg
cyclophosphamid
melphalan
busulfan
mitot
spindl
inhibitor
eg
paclitaxel
docetaxel
vinblastin
vincristin
topoisomeras
inhibitor
eg
etoposid
doxorubicin
antimetabolit
eg
methotrex
bhatt
saleem
weiss
wailoo
et
al
decreas
neutrophil
count
expect
chemotherapeut
treatment
easili
monitor
serial
cbc
sever
enough
increas
risk
lifethreaten
infect
clinic
treatment
empir
antibiot
gcsflike
compound
may
consid
suppress
granulopoiesi
direct
granulocyt
toxic
also
report
nonchemotherapeut
agent
dosedepend
inhibit
colonyform
unit
granulocyt
macrophag
bone
marrow
report
sever
anticonvuls
drug
includ
valproic
acid
carbamazepin
betalactam
antibiot
schwartzberg
irvin
et
al
watt
et
al
neftel
et
al
sever
anticonvuls
drug
includ
ethosuximid
mintzer
et
al
phenytoin
sharafuddin
et
al
report
caus
direct
toxic
effect
granulocyt
precursor
antipsychot
agent
includ
clozapin
chlorpromazin
may
also
caus
direct
cytotox
effect
neutrophil
metabol
clozapin
demonstr
form
unstabl
intracellular
metabolit
nitrenium
ion
deplet
glutathion
make
neutrophil
suscept
oxid
damag
apoptosi
william
et
al
chlorpromazin
may
caus
cytotox
inhibit
thymidin
uracil
uptak
neutrophil
pisciotta
kaldahl
thienopyridin
inhibitor
platelet
aggreg
includ
clopidogrel
ticlopidin
also
associ
direct
neutrophil
toxic
result
mitochondri
toxic
metabolit
gener
myeloperoxidas
metabol
parent
compound
maseneni
et
al
maseneni
et
al
product
lymphocyt
lymphopoiesi
progress
pluripot
hematopoiet
stem
cell
differenti
common
lymphoid
progenitor
cell
differenti
bcell
tcell
natur
killer
nk
cell
bcell
develop
begin
fetal
liver
transit
bone
marrow
postnat
cell
undergo
prolifer
differenti
follow
migrat
peripher
lymphoid
tissu
bcell
develop
requir
varieti
solubl
factor
includ
infg
tgfb
burkhard
tcell
precursor
migrat
thymu
embryon
develop
undergo
prolifer
differenti
posit
neg
select
tcell
develop
requir
stimul
burkhard
nkcell
develop
requir
stimul
occur
mostli
fetal
liver
thymu
well
bone
marrow
birth
burkhard
health
blood
lymphocyt
predominantli
tcell
similar
neutrophil
blood
lymphocyt
divid
circul
margin
pool
cell
frequent
shift
pool
lymphocyt
blood
travel
lymph
node
exit
blood
high
endotheli
venul
enter
lymph
node
cortic
lymphocyt
migrat
lymph
node
leav
effer
lymphat
vessel
return
blood
blood
lymphocyt
may
also
emigr
tissu
chemotact
stimuli
present
tissu
lymphocyt
may
prolifer
die
migrat
back
blood
lymphocyt
life
span
highli
variabl
depend
cell
type
function
lymphocyt
may
live
year
stockham
scott
lymphocyt
numer
blood
leukocyt
rat
mice
typic
present
greater
number
neutrophil
young
cynomolgu
monkey
dog
cynomolgu
monkey
use
nonclin
toxicolog
studi
often
young
peripubert
greater
lymphocyt
neutrophil
count
howev
cynomolgu
monkey
dog
shift
blood
leukocyt
popul
predomin
neutrophil
matur
nonclin
toxicolog
studi
may
includ
anim
either
hematolog
pattern
adult
speci
neutrophil
numer
blood
leukocyt
lymphocyt
typic
second
numer
agerel
lymphocyt
common
predomin
blood
leukocyt
neonat
juvenil
anim
even
speci
predomin
neutrophil
circul
adult
recognit
appar
lymphocytosi
young
anim
import
comparison
lymphocyt
count
young
anim
adult
histor
control
data
may
give
appear
increas
lymphocyt
count
speci
lymphocytosi
young
anim
describ
includ
dog
cat
stockham
scott
cynomolgu
monkey
sugimoto
et
al
shift
predominantli
lymphocyt
predominantli
neutrophil
circul
occur
around
year
old
cynomolgu
monkey
sugimoto
et
al
uncommon
nonclin
toxicolog
studi
includ
individu
lymphocyt
neutrophilpredomin
leukogram
catecholamineinduc
similar
increas
neutrophil
count
increas
endogen
exogen
catecholamin
associ
excit
fear
exercis
result
transient
increas
lymphocyt
count
catecholamineinduc
increas
lymphocyt
count
associ
rapid
shift
margin
circul
lymphocyt
pool
thought
due
decreas
lymphocyt
adhes
endotheli
cell
increas
blood
flow
benschop
et
al
releas
lymphocyt
spleen
respons
catecholamin
stimul
like
also
contribut
increas
blood
lymphocyt
count
lymph
node
bone
marrow
appear
signific
contributor
benschop
et
al
speci
differ
respons
lymphocyt
catecholamin
result
increas
lymphocyt
tend
common
monkey
cat
less
common
adult
dog
schultz
glucocorticoid
neg
effect
blood
lymphocyt
count
due
effect
lymphocyt
distribut
bodi
suppress
lymphopoiei
hypoadrenocortic
addison
diseas
adren
gland
unabl
maintain
normal
concentr
glucocorticoid
may
associ
increas
blood
lymphocyt
count
due
loss
inhibitori
effect
endogen
glucocorticoid
oelker
stockham
scott
averi
averi
acut
inflammatori
process
tend
caus
decreas
lymphocyt
count
acut
infecti
process
particularli
sever
viral
infect
may
caus
increas
lymphocyt
count
howev
increas
lymphocyt
count
commonli
observ
chronic
inflammatori
process
chronic
stimul
lymphocyt
antigen
cytokin
result
increas
product
lymphocyt
releas
blood
caus
increas
blood
lymphocyt
count
reactiv
lymphocyt
may
observ
blood
accompani
inflammationinduc
increas
lymphocyt
count
reactiv
lymphocyt
spectrum
morpholog
chang
includ
increas
cytoplasm
basophilia
larg
cell
mildli
increas
amount
cytoplasm
lower
nuclear
cytoplasm
ratio
variabl
pattern
chromatin
clump
variabl
number
visibl
nucleoli
occasion
reactiv
lymphocyt
may
paranuclear
cytoplasm
clear
give
plasmacytoid
appear
infecti
mononucleosi
syndrom
peopl
rel
common
caus
inflammatori
reactiv
increas
lymphocyt
count
usual
acut
vasu
caligiuri
chronic
infect
lead
increas
blood
lymphocyt
count
may
includ
viscer
leishmaniasi
parasit
infect
strongyloidiasi
leprosi
vasu
caligiuri
rai
et
al
myer
et
al
sever
chronic
infect
includ
ehrlichiosi
rocki
mountain
spot
fever
leishmaniasi
trypanosomiasi
brucellosi
associ
increas
blood
lymphocyt
count
dog
schultz
neoplasia
increas
blood
lymphocyt
count
associ
lymphoprolif
neoplasia
may
repres
either
lymphocyt
leukemia
leukem
phase
lymphoma
normal
circul
lymphocyt
popul
heterogen
predominantli
small
lymphocyt
fewer
intermedi
larg
lymphocyt
increas
blood
lymphocyt
count
loss
heterogen
blood
lymphocyt
popul
predominantli
monomorph
intermedi
larg
lymphocyt
popul
key
featur
diagnos
lymphoprolif
neoplasia
except
chronic
lymphocyt
leukemia
character
increas
number
small
lymphocyt
subtl
morpholog
alter
circul
lymphocyt
often
abnorm
morpholog
featur
may
observ
microscop
abnorm
morpholog
featur
leukem
lymphocyt
popul
may
includ
increas
cytoplasm
basophilia
increas
amount
cytoplasm
alter
nuclear
cytoplasm
ratio
irregular
clump
nuclear
chromatin
indent
lobul
nuclei
variabl
size
typic
promin
nucleoli
multipl
nucleoli
morpholog
featur
similar
observ
reactiv
lymphocyt
two
process
may
distinguish
overal
heterogen
lymphocyt
popul
proport
lymphocyt
popul
morpholog
alter
addit
test
flow
cytometri
phenotyp
pcr
antigen
receptor
rearrang
parr
also
aid
diagnosi
character
lymphoprolif
neoplasia
lymphoprolif
neoplasia
observ
rel
common
background
find
older
rat
mice
nonclin
toxicolog
studi
frith
et
al
although
less
common
may
also
observ
low
frequenc
older
monkey
monkey
concurr
infect
speciesspecif
lymphocryptovirus
immunosuppress
report
virusrel
lymphoprolif
neoplasia
magden
et
al
lymphocryptovirus
gammaherpesvirina
subfamili
relat
epsteinbarr
viru
associ
lymphoprolif
neoplasia
peopl
may
aberrantli
infect
new
world
monkey
magden
et
al
thorleylawson
gross
increas
blood
lymphocyt
count
may
also
occur
secondari
nonlymphoprolif
neoplasm
increas
polyclon
tcell
report
patient
malign
thymoma
increas
reactiv
lymphocyt
report
aml
system
mastocytosi
vasu
caligiuri
xenobioticinduc
xenobioticinduc
increas
blood
lymphocyt
count
rel
uncommon
report
associ
administr
catecholamin
rare
idiosyncrat
hypersensitivitytyp
reaction
administr
exogen
catecholamin
epinephrin
adrenerg
agonist
similar
effect
blood
lymphocyt
count
mediat
endogen
catecholamin
rapid
shift
lymphocyt
margin
circul
blood
pool
well
mobil
lymphocyt
spleen
contribut
increas
lymphocyt
count
lymphocyt
appear
adrenerg
effect
primarili
mediat
b
adrenerg
receptor
benschop
et
al
increas
blood
lymphocyt
count
presenc
atyp
lymphocyt
circul
associ
drug
reaction
eosinophilia
system
symptom
dress
form
drugrel
hypersensit
sever
anticonvuls
drug
includ
phenobarbit
phenytoin
allopurinol
minocyclin
sulfonamid
gold
salt
dapson
associ
dress
roujeau
callot
et
al
treatment
cml
chronic
lymphocyt
leukemia
dasatinib
ibrutinib
respect
associ
increas
blood
lymphocyt
count
vasu
caligiuri
dasatinibrel
increas
lymphocyt
count
may
relat
expans
tcell
nkcell
popul
increas
infg
report
favor
outcom
treatment
ibrutinibrel
increas
lymphocyt
count
may
relat
increas
efflux
lymphocyt
lymphoid
tissu
vasu
caligiuri
glucocorticoidinduc
endogen
glucocorticoid
may
increas
chronic
stress
hyperadrenocortic
decreas
lymphocyt
count
tend
promin
consist
glucocorticoidmedi
leukocyt
chang
across
speci
glucocorticoid
induc
decreas
blood
lymphocyt
count
sever
mechan
addit
rapid
shift
lymphocyt
circul
margin
tissu
pool
evid
lymphocyt
redistribut
blood
bone
marrow
fauci
decreas
efflux
lymphocyt
lymphoid
tissu
bloemena
et
al
contribut
shift
lymphocyt
tissu
pool
longterm
increas
glucocorticoid
concentr
lymphotox
may
observ
due
increas
activ
apoptot
pathway
garvi
et
al
tuckermann
et
al
rat
feed
restrict
associ
decreas
blood
lymphocyt
count
lymphocyt
deplet
variou
lymphoid
tissu
moriyama
et
al
possibl
associ
prolong
stress
therefor
glucocorticoidmedi
effect
indirect
test
articlerel
effect
mediat
alter
food
consumpt
import
consid
nonclin
toxicolog
studi
test
articl
may
caus
direct
indirect
hematolog
effect
interpret
chang
includ
stressassoci
effect
must
made
cautious
thought
use
weight
evid
approach
decreas
lymphocyt
count
typic
observ
acut
inflamm
decreas
like
due
increas
margin
emigr
lymphocyt
site
inflamm
increas
migrat
lymphocyt
lymphoid
tissu
decreas
efflux
lymphocyt
lymphoid
tissu
stockham
scott
stress
associ
ill
acut
inflamm
may
also
contribut
glucocorticoidinduc
mechan
stockham
scott
schultz
mani
infecti
agent
may
caus
decreas
lymphocyt
count
due
inflamm
infecti
agent
associ
decreas
lymphocyt
count
includ
virus
coronaviru
parvoviru
west
nile
viru
hepat
virus
influenza
vasu
caligiuri
schultz
acut
system
bacteri
infect
well
tuberculosi
typhoid
fever
bacteri
pneumonia
vasu
caligiuri
magden
et
al
acut
phase
malaria
may
also
associ
decreas
lymphocyt
count
vasu
caligiuri
infect
immunodefici
virus
includ
human
simian
felin
immunodefici
virus
may
result
destruct
infect
noninfect
lymphocyt
hiv
directli
infect
tcell
via
molecul
infect
cell
migrat
lymphoid
tissu
viru
replic
infect
tcell
chinen
shearer
hivmedi
lymphocyt
destruct
like
multifactori
hiv
may
cytotox
directli
induc
tcell
apoptosi
induc
tcell
death
nonspecif
immun
respons
caus
tcell
death
stimul
autophagocyt
pathway
chinen
shearer
stump
vandewoud
siv
fiv
tropism
tcell
also
mediat
receptor
express
tcell
stump
vandewoud
simian
betaretroviru
also
caus
decreas
blood
lymphocyt
count
due
infect
eventu
deplet
bcell
tcell
although
infect
nonlymphoid
cell
also
occur
montiel
immunemedi
destruct
lymphocyt
uncommon
occur
autoimmun
diseas
sle
immunemedi
decreas
lymphocyt
count
typic
occur
concurr
cutan
arthrit
neurolog
disord
stone
may
result
autoantibodi
caus
lymphocyt
destruct
death
apoptosi
lu
et
al
massardo
et
al
noguchi
et
al
budman
steinberg
although
rare
inherit
immunodefici
syndrom
caus
blood
lymphocyt
count
decreas
one
exampl
sever
combin
immunodefici
scid
report
human
dog
mice
hors
suter
notarangelo
meek
et
al
felsberg
et
al
custer
et
al
scid
may
inherit
autosom
recess
xlink
recess
pattern
caus
consist
decreas
tcell
concurr
decreas
bcell
nkcell
form
diseas
scid
human
caus
varieti
mechan
includ
adenosin
deaminas
defici
result
earli
cell
death
due
metabolit
accumul
common
gamma
chain
janu
kinas
mutat
caus
decreas
surviv
tcell
precursor
due
defect
cytokin
signal
recombinaseactiv
gene
mutat
caus
defect
v
j
rearrang
bcell
tcell
receptor
mutat
caus
defect
tcell
receptor
signal
suter
notarangelo
scid
jack
russel
terrier
arabian
foal
mice
demonstr
caus
defect
v
j
recombin
due
loss
dnadepend
protein
kinas
meek
et
al
xlink
scid
describ
bassett
hound
welsh
corgi
dog
suter
inherit
immunodefici
syndrom
result
decreas
blood
lymphocyt
count
includ
reticular
dysgenesi
ataxiatelangiectasia
wiskottaldrich
syndrom
vasu
caligiuri
although
uncommon
disord
caus
chronic
loss
lymphocyterich
lymph
fluid
lead
bodi
deplet
lymphocyt
decreas
blood
lymphocyt
count
exampl
condit
includ
proteinlos
enteropathi
lymphangiectasia
ulcer
enter
repeat
iatrogen
remov
chylothorac
fluid
vasu
caligiuri
schultz
stockham
scott
although
lymphoprolif
neoplasia
may
associ
increas
lymphocyt
count
previous
discuss
lymphoma
lymphocyt
leukemia
may
also
associ
decreas
lymphocyt
count
includ
alter
lymphocyt
recircul
pattern
decreas
product
nonneoplas
lymphocyt
secondari
lymphoid
organ
damag
mitrov
et
al
schultz
stockham
scott
lymphoid
suppress
common
find
mani
xenobiot
may
associ
decreas
blood
lymphocyt
count
mechan
decreas
occur
may
either
part
expect
pharmacolog
compound
may
repres
offtarget
effect
sever
exampl
xenobioticinduc
decreas
lymphocyt
count
describ
administr
exogen
glucocorticoid
antiinflammatori
immunosuppress
purpos
result
decreas
blood
lymphocyt
count
mechan
endogen
glucocorticoid
includ
alter
blood
tissu
pool
distribut
decreas
efflux
lymphocyt
lymphoid
tissu
increas
lymphocyt
apoptosi
prolong
glucocorticoid
exposur
immunosuppress
agent
caus
decreas
blood
lymphocyt
count
includ
cyclophosphamid
methotrex
purin
nucleosid
analog
azathioprin
cyclophosphamid
associ
profound
decreas
blood
lymphocyt
count
effect
lymphocyt
subtyp
gerg
methotrex
caus
decreas
circul
tcell
cladribin
purin
nucleosid
analog
caus
apoptosi
lymphocyt
report
affect
tcell
gerg
azothiaprineinduc
decreas
blood
lymphocyt
count
appear
due
longterm
administr
high
dose
level
johnson
et
al
gerg
discuss
previous
numer
xenobiot
associ
druginduc
sle
peopl
decreas
lymphocyt
case
like
due
product
autoantibodi
subsequ
lymphocyt
destruct
similar
nonxenobioticinduc
sle
xenobiot
associ
sle
includ
sever
anticonvuls
phenothiazin
chlorpromazin
valproat
sever
antibiot
penicillin
streptomycin
tetracyclin
griseofulvin
sulphonamid
miscellan
xenobiot
captopril
phenylbutazon
lovastatin
stone
mutasim
adam
chemotherapeut
agent
also
frequent
associ
decreas
lymphocyt
count
may
preced
episod
febril
neutropenia
gerg
carboplatin
dacarbazin
paclitaxel
report
induc
decreas
tcell
epirubicin
mitomycin
appear
affect
tcell
greater
degre
tcell
pentostatin
affect
bcell
tcell
popul
gerg
antilymphocyt
monoclon
antibodi
use
treat
autoimmun
diseas
well
caus
immunosuppress
prevent
acut
transplant
reject
exampl
monoclon
antibodi
includ
muromonab
vial
et
al
gerg
class
drug
report
caus
decreas
lymphocyt
count
vari
pesticid
includ
organochlorid
pesticid
pentachlorophenol
organotin
compound
organophosph
corsini
et
al
thienopyridin
clopidogrel
ticlopidin
caus
direct
lymphotox
high
concentr
maseneni
et
al
histamin
receptor
antagonist
cimetidin
anticonvuls
carbamazepin
imidazol
use
treat
fungal
infect
opioid
morphin
gerg
bone
marrow
common
myeloid
progenitor
differenti
monocyt
lineag
stimul
stem
cell
factor
gmcsf
macrophagecolonystimul
factor
mcsf
papenfuss
monoblast
differenti
promonocyt
monocyt
blood
monocyt
distribut
circul
margin
pool
margin
pool
monocyt
emigr
tissu
circul
halflif
monocyt
mice
report
rang
h
provench
bollig
et
al
macrophag
dendrit
cell
aris
monocyt
monocyt
precursor
depend
local
tissu
microenviron
cytokin
stimul
papenfuss
form
mononuclear
phagocyt
system
although
present
low
number
monocyt
repres
third
numer
blood
leukocyt
health
neutrophil
lymphocyt
typic
largest
leukocyt
routin
blood
film
monocyt
play
major
role
resolut
infecti
process
particularli
involv
larger
complex
organ
fungi
protozoa
clearanc
foreign
materi
bodi
follow
cardiac
blood
collect
mice
tissu
macrophag
may
inadvert
collect
may
rare
observ
blood
smear
evalu
catecholamineinduc
although
less
commonli
observ
increas
neutrophil
lymphocyt
count
blood
monocyt
count
may
modestli
increas
stimul
endogen
catecholamin
effect
like
mediat
rapid
shift
monocyt
margin
pool
circul
pool
everd
et
al
endogen
glucocorticoid
classic
caus
increas
blood
monocyt
count
howev
increas
monocyt
count
less
consist
observ
decreas
lymphocyt
count
increas
neutrophil
count
percept
chang
monocyt
count
may
occur
hall
everd
et
al
also
report
decreas
monocyt
count
attribut
endogen
glucocorticoid
may
associ
decreas
product
prolong
glucocorticoid
exposur
thompson
van
furth
may
transient
follow
increas
monocyt
count
steer
et
al
rinehart
et
al
increas
blood
monocyt
count
occur
acut
chronic
inflamm
inflammatori
increas
monocyt
may
associ
infecti
noninfecti
etiolog
tuberculosi
mycobacteri
infect
commonli
associ
increas
monocyt
count
may
repres
increas
tissu
demand
macrophag
lichtman
increas
monocyt
count
also
associ
bacteri
endocard
sepsi
osteomyel
variou
pyogranulomat
diseas
candidiasi
viral
infect
includ
cytomegaloviru
influenza
sever
parasit
diseas
includ
pneumocystosi
entopolypoid
macacai
infect
old
world
monkey
ape
dirofilariasi
dog
lichtman
magden
et
al
schultz
howev
increas
monocyt
count
may
less
commonli
relat
malaria
leishmaniasi
rickettsi
diseas
peopl
previous
thought
lichtman
noninfecti
caus
increas
blood
monocyt
count
includ
inflammatori
bowel
diseas
ulcer
gastriti
myocardi
infarct
parturit
lichtman
immun
disord
numer
immun
disord
associ
increas
blood
monocyt
count
immunemedi
destruct
erythrocyt
neutrophil
often
concurr
increas
monocyt
count
schultz
stockham
scott
increas
monocyt
count
associ
immunemedi
neutropenia
may
due
cytokin
stimul
common
precursor
granulocyt
monocyt
stockham
scott
rebound
increas
neutrophil
count
recoveri
agranulocytosi
often
concurr
increas
monocyt
count
lichtman
schultz
may
also
due
stimul
common
granulocyt
monocyt
precursor
system
lupu
erythematosu
budman
steinberg
rheumatoid
arthriti
buchan
et
al
sarcoidosi
goodwin
et
al
connect
tissu
diseas
lichtman
may
also
caus
increas
monocyt
count
neoplasia
hematopoiet
malign
involv
monocyt
lineag
rare
commonli
associ
increas
blood
monocyt
count
hematopoiet
neoplasm
includ
myelodysplast
syndrom
eg
chronic
myelomonocyt
leukemia
acut
monocyt
leukemia
acut
myelomonocyt
leukemia
dendrit
cell
leukemia
malign
histiocytosi
schultz
tefferi
vardiman
villeneuv
et
al
sun
et
al
lichtman
segel
castoldi
rigolin
rigolin
et
al
laurencet
et
al
blood
monocyt
associ
hematopoiet
neoplasm
frequent
abnorm
morpholog
featur
may
accompani
monoblast
promonocyt
circul
increas
monocyt
count
relat
neoplasia
limit
hematopoiet
neoplasm
monocyt
lineag
increas
monocyt
count
also
describ
associ
wide
spectrum
lymphoprolif
neoplasm
soft
tissu
sarcoma
hemangiosarcoma
chondrosarcoma
rectal
polyp
colon
cancer
lichtman
schultz
melichar
et
al
ruka
et
al
one
studi
half
patient
solid
tumor
malign
report
concurr
increas
monocyt
count
independ
tumor
metastasi
barrett
xenobioticinduc
administr
exogen
glucocorticoid
classic
caus
increas
monocyt
count
although
effect
may
inconsist
observ
chang
blood
monocyt
count
may
occur
studi
demonstr
transient
decreas
monocyt
count
occur
immedi
follow
administr
exogen
glucocorticoid
subsequ
increas
monocyt
count
rinehart
et
al
steer
et
al
other
report
increas
monocyt
count
exogen
glucocorticoid
administr
barker
et
al
administr
exogen
cytokin
may
also
result
increas
blood
monocyt
count
increas
blood
monocyt
count
observ
gcsf
ranaghan
et
al
liu
et
al
gmcsf
schmitz
et
al
mcsf
weiner
et
al
cole
et
al
administr
chernoff
et
al
mcsf
administrationrel
increas
monocyt
count
associ
concurr
doselimit
decreas
platelet
count
weiner
et
al
cole
et
al
increas
monocyt
count
also
report
patient
associ
pseudolymphoma
syndrom
caus
therapi
sever
anticonvuls
includ
phenytoin
phenobarbit
valproic
acid
choi
et
al
decreas
monocyt
count
may
difficult
detect
due
rel
low
blood
monocyt
count
human
laboratori
anim
speci
particularli
refer
interv
histor
control
rang
rather
valu
concurr
control
group
use
determin
chang
blood
monocyt
count
present
nonclin
toxicolog
studi
comparison
concurr
control
pretest
may
enabl
detect
subtl
decreas
monocyt
count
immunemedi
immunemedi
decreas
monocyt
count
typic
observ
isol
associ
caus
pancytopenia
aplast
anemia
aplast
anemia
destruct
earli
hematopoiet
precursor
result
loss
product
hematopoiet
cell
lineag
subsequ
develop
sever
decreas
multipl
blood
compon
count
aplast
anemia
also
occur
nonimmunemedi
condit
anorexia
nervosa
abella
et
al
uncommonli
case
inherit
mark
decreas
blood
monocyt
count
human
autosom
domin
inherit
pattern
associ
decreas
monocyt
count
result
increas
suscept
mycobacteria
varieti
infecti
agent
vinh
et
al
mutat
transcript
factor
regul
hematopoiet
cell
gene
express
integr
report
caus
autosom
domin
decreas
blood
monocyt
count
camargo
et
al
hsu
et
al
decreas
blood
monocyt
count
may
occur
secondari
hematolog
malign
metastat
nonhematolog
malign
effac
bone
marrow
neoplast
myelophthisi
result
decreas
product
normal
hematopoiet
cell
therefor
blood
compon
count
includ
monocyt
exampl
report
condit
includ
hairi
cell
leukemia
den
ottoland
et
al
ratain
et
al
chronic
lymphocyt
leukemia
de
rossi
et
al
xenobioticinduc
bone
marrow
suppress
often
caus
decreas
blood
monocyt
count
combin
decreas
blood
compon
count
caus
includ
chemotherapeut
agent
discuss
xenobioticinduc
decreas
neutrophil
count
due
direct
hematopoiet
precursor
cell
toxic
xenobiot
associ
aplast
anemia
chloramphenicol
monocyt
cytotox
report
methylmetacryl
monom
use
joint
replac
surgeri
dahl
et
al
lindan
pesticid
report
caus
cfugm
cytotox
parentmassin
thouvenot
eosinophil
share
common
earli
myeloid
precursor
neutrophil
earli
prolifer
eosinophil
lineag
appear
larg
due
stimul
myeloid
precursor
gmcsf
play
critic
role
termin
eosinophil
differenti
matur
sanderson
similar
granulocyt
eosinophil
distribut
prolifer
matur
pool
bone
marrow
circul
margin
pool
blood
bone
marrow
primari
site
eosinophil
product
although
rat
eosinophil
migrat
complet
matur
spleen
young
meadow
earli
prolifer
bone
marrow
eosinophil
usual
indistinguish
microscop
earli
myeloid
precursor
characterist
granul
begin
form
late
promyelocyt
stage
radin
wellman
time
product
matur
eosinophil
myeloblast
stage
day
halflif
matur
eosinophil
circul
rang
less
h
although
transit
time
vari
speci
young
meadow
eosinophil
migrat
tissu
circul
live
day
unless
stimul
occur
young
meadow
eosinophil
count
normal
low
speci
make
detect
decreas
eosinophil
count
difficult
similar
detect
decreas
monocyt
count
comparison
treat
group
concurr
control
pretest
valu
nonclin
toxicolog
studi
aid
identif
chang
eosinophil
count
eosinophil
morpholog
distinct
leukocyt
due
larg
pinkstain
cytoplasm
granul
howev
speci
differ
granul
size
shape
stain
properti
exist
blood
eosinophil
count
health
gener
exceed
basophil
count
decreas
glucocorticoid
although
uncommon
decreas
endogen
glucocorticoid
concentr
due
hypoadrenocortic
associ
mild
increas
blood
eosinophil
count
wardlaw
stockham
scott
effect
like
due
loss
glucocorticoidassoci
shift
blood
eosinophil
margin
pool
well
lack
proapoptot
stimul
glucocorticoid
eosinophil
precursor
acut
chronic
inflammatori
stimul
may
result
increas
blood
eosinophil
count
along
increas
neutrophil
lymphocyt
andor
monocyt
count
howev
inflammatori
process
stimul
primarili
eosinophil
respons
may
also
occur
eotaxin
rant
cytokin
chemokin
select
stimul
eosinophil
respons
sampson
common
inflammatori
process
involv
eosinophil
includ
parasit
allergyinduc
inflamm
parasit
consid
common
caus
increas
blood
eosinophil
count
worldwid
wardlaw
helminth
eg
nematod
trematod
cestod
infect
major
caus
tefferi
et
al
leder
weller
inflammatori
increas
eosinophil
count
respons
helminth
cytokin
eg
mediat
valent
ige
histamin
releas
mast
cell
anaphylatoxin
eg
product
complement
activ
helper
tcell
activ
direct
stimul
eosinophil
helminth
antigen
also
play
role
eosinophil
recruit
wardlaw
leder
weller
mcewen
helminth
migrat
host
tissu
key
factor
stimul
increas
blood
eosinophil
tissu
eosinophil
inflamm
helminth
remain
confin
intestin
lumen
may
result
eosinophil
respons
leder
weller
degre
eosinophil
respons
increas
blood
eosinophil
count
also
depend
parasit
burden
matur
distribut
tissu
leder
weller
ascariasi
strongyloidiasi
trichinosi
filariasi
ancylosomiasi
associ
increas
eosinophil
count
human
wardlaw
tefferi
et
al
leder
weller
mani
may
also
observ
common
laboratori
speci
schultz
magden
et
al
korenaga
et
al
ogilvi
et
al
helminth
infect
purposebr
laboratori
anim
uncommonli
observ
nonclin
toxicolog
studi
due
breed
hous
facil
biosecur
measur
sever
less
commonli
use
larg
anim
speci
sourc
farm
pig
calv
sheep
helminth
infect
frequent
observ
infect
nonhelminth
parasit
may
also
caus
increas
blood
eosinophil
count
ectoparasit
includ
flea
tick
associ
increas
eosinophil
count
dog
cat
may
due
arthropodrel
allerg
hypersensit
reaction
schultz
valenciano
et
al
stockham
scott
sever
protozo
infect
includ
isosporiasi
jongwutiw
et
al
junod
toxoplasmosi
grant
klein
may
result
increas
blood
eosinophil
count
howev
protozo
agent
infect
erythrocyt
plasmodium
babesia
speci
gener
expect
result
alter
blood
eosinophil
count
tefferi
et
al
stockham
scott
bacteri
infect
includ
borreliosi
granter
et
al
rickettsiosi
wardlaw
sever
viral
infect
includ
herp
viru
hiv
wardlaw
tietz
et
al
also
associ
increas
blood
eosinophil
count
fungal
infect
caus
allerg
inflamm
coccidiomycosi
candidiasi
aspergillosi
wardlaw
may
also
caus
increas
blood
eosinophil
count
allerg
inflamm
anoth
common
caus
increas
blood
eosinophil
count
allerg
condit
associ
increas
blood
eosinophil
count
includ
asthma
atop
dermat
allerg
rhiniti
although
increas
eosinophil
count
condit
usual
mild
wardlaw
allerg
inflamm
associ
immedi
releas
ige
consid
type
hypersensit
reaction
allergeninduc
inflamm
may
attribut
type
iv
delayedtyp
cellmedi
hypersensit
follow
h
activ
subsequ
eosinophil
recruit
howev
differ
observ
atop
dermat
classic
type
iv
hypersensit
gaga
et
al
h
mediat
allerg
inflamm
may
repres
true
type
iv
hypersensit
reaction
form
inflammatori
increas
blood
eosinophil
count
product
cytokin
chemokin
eotaxin
appear
play
major
role
allerg
asthma
activ
thelper
type
h
cell
releas
stimul
releas
cytokin
chemokin
result
recruit
activ
eosinophil
rosenberg
et
al
sensit
airway
ovalbumin
subsequ
challeng
mice
mimick
mani
clinic
patholog
featur
allerg
asthma
includ
interact
h
cell
eosinophil
rosenberg
et
al
howev
asthma
encompass
heterogen
set
phenotyp
form
demonstr
clinic
improv
respons
therapi
target
eosinophil
wegmann
asthma
uncommon
laboratori
anim
speci
experiment
induc
mice
may
occur
natur
cat
activ
h
h
cell
propos
contribut
patholog
atop
dermat
h
activ
particular
relev
develop
increas
blood
eosinophil
count
grew
et
al
similar
allerg
asthma
activ
h
cell
also
play
role
cytokin
chemokin
elabor
eosinophil
recruit
allerg
rhiniti
although
effect
eosinophil
allerg
rhiniti
also
mediat
histamin
ige
releas
mast
cell
histamin
releas
basophil
borish
inflammatori
increas
blood
eosinophil
count
also
associ
paraneoplast
syndrom
like
relat
increas
may
liber
activ
h
cell
directli
neoplasm
lymphoma
includ
tand
bcell
lymphoma
common
caus
paraneoplast
increas
eosinophil
count
multipl
speci
includ
human
dog
cat
hors
wardlaw
davi
rothenberg
valent
schultz
valenciano
et
al
stockham
scott
marchetti
et
al
cave
et
al
duckett
matthew
howev
mani
nonlymphoid
tumor
also
associ
paraneoplast
increas
blood
eosinophil
count
includ
mammari
carcinoma
hepatocellular
carcinoma
squamou
cell
carcinoma
thymoma
nonsmallcel
lung
cancer
mast
cell
diseas
includ
system
mastocytosi
mast
cell
leukemia
schultz
balian
et
al
walter
et
al
pandit
et
al
valent
myeloid
neoplasm
result
clonal
eosinophil
expans
increas
blood
eosinophil
count
expans
tefferi
et
al
neoplast
increas
eosinophil
count
associ
acut
eosinophil
leukemia
chronic
eosinophil
leukemia
chronic
myeloid
leukemia
myelodysplast
syndrom
wardlaw
tefferi
et
al
schultz
clonal
increas
eosinophil
count
may
difficult
distinguish
idiopath
hypereosinophil
syndrom
cytogenet
analysi
may
necessari
numer
cytogenet
abnorm
report
clonal
increas
eosinophil
count
tefferi
et
al
numer
report
idiopath
increas
blood
eosinophil
count
condit
includ
eosinophil
esophag
eosinophil
gastroenter
eosinophil
myositi
eosinophil
cellul
eosinophil
pneumon
peopl
dog
andor
cat
wardlaw
stockham
scott
hypereosinophil
syndrom
he
peopl
anoth
condit
fall
umbrella
idiopath
increas
eosinophil
count
he
chronic
increas
eosinophil
count
observ
without
evid
underli
caus
condit
condit
associ
mark
tissu
infiltr
eventu
organ
damag
failur
wardlaw
rosenberg
et
al
howev
patient
he
eventu
develop
either
lymphoid
myeloid
neoplasm
wardlaw
mice
autom
hematolog
analyzergener
blood
eosinophil
count
may
fals
elev
larg
platelet
clump
present
specimen
oconnel
et
al
platelet
clump
mice
extrem
common
blood
smear
evalu
often
necessari
confirm
autom
leukocyt
differenti
count
xenobioticinduc
beta
adrenerg
block
agent
may
associ
modest
increas
eosinophil
count
administr
propranolol
demonstr
prevent
catecholamineinduc
decreas
eosinophil
count
reed
et
al
kochwes
antibiot
tetracyclin
associ
increas
eosinophil
count
dog
domina
et
al
human
ho
et
al
therapeut
administr
renal
cell
carcinoma
also
report
caus
increas
blood
eosinophil
count
wardlaw
administr
gcsf
gmcsf
also
caus
increas
blood
eosinophil
count
due
stimul
common
myeloid
precursor
prolifer
howev
increas
eosinophil
count
compound
small
comparison
increas
blood
neutrophil
count
numer
reaction
xenobiot
also
caus
increas
blood
eosinophil
count
acut
gener
exanthemat
pustulosi
due
drug
aminopenicillin
diltiazem
discuss
xenobioticinduc
increas
neutrophil
count
may
associ
concurr
increas
eosinophil
count
roujeau
drug
reaction
eosinophilia
system
syndrom
dress
predominantli
cutan
manifest
drug
hypersensit
reaction
numer
compound
associ
dress
includ
sever
anticonvuls
drug
phenobarbit
phenytoin
allopurinol
minocyclin
sulfonamid
gold
salt
dapson
spironolacton
roujeau
callot
et
al
tefferi
et
al
ghislain
et
al
catecholamineinduc
contrast
neutrophil
lymphocyt
monocyt
count
blood
eosinophil
count
decreas
respons
increas
endogen
catecholamin
effect
may
inconsist
difficult
detect
due
time
blood
collect
rel
rapid
chang
eosinophil
count
normal
low
blood
eosinophil
count
badrenerg
effect
epinephrin
believ
caus
decreas
blood
eosinophil
count
kochwes
catecholamin
may
also
caus
decreas
releas
eosinophil
bone
marrow
mcewen
glucocorticoidinduc
decreas
blood
eosinophil
count
classic
featur
glucocorticoid
leukogram
occur
conjunct
decreas
lymphocyt
count
usual
increas
neutrophil
count
blood
eosinophil
appear
particularli
respons
effect
glucocorticoid
concurr
decreas
blood
lymphocyt
eosinophil
count
common
laboratori
speci
use
nonclin
toxicolog
studi
good
indic
stress
hall
glucocorticoid
caus
shift
blood
eosinophil
circul
margin
pool
well
decreas
releas
eosinophil
bone
marrow
mcewen
may
also
contribut
decreas
blood
eosinophil
count
inhibit
prosurviv
stimul
direct
induct
apoptosi
druilh
et
al
wallen
et
al
sever
acut
overwhelm
inflamm
associ
sepsi
may
caus
eosinopenia
conjunct
neutropenia
studi
mice
demonstr
decreas
blood
eosinophil
associ
sever
acut
inflamm
occur
rapidli
increas
glucocorticoid
bass
inject
materi
inflammatori
exud
adrenalectom
mice
still
result
deceas
eosinophil
count
bass
indic
mechan
eosinophil
decreas
acut
inflamm
independ
adren
function
believ
acut
inflammatori
decreas
blood
eosinophil
count
due
shift
eosinophil
circul
margin
pool
subsequ
egress
tissu
respons
chemotact
stimuli
acut
inflamm
associ
fungal
viral
infect
also
tend
caus
decreas
eosinophil
count
leder
weller
although
decreas
eosinophil
count
rel
uncommon
except
administr
exogen
glucocorticoidbas
xenobiot
may
also
observ
case
xenobioticinduc
bone
marrow
suppress
aplast
anemia
situat
decreas
eosinophil
count
occur
isol
gener
observ
concurr
decreas
neutrophil
lymphocyt
andor
monocyt
count
xenobiot
caus
bone
marrow
suppress
classic
includ
chemotherapeut
agent
xenobiot
sporad
associ
aplast
anemia
includ
chloramphenicol
anticonvuls
phenytoin
xenobiot
associ
bone
marrow
suppress
aplast
anemia
describ
detail
previou
leukocyt
subtyp
section
basophil
develop
bone
marrow
uncommit
myeloid
progenitor
cell
differenti
commit
basophil
progenitor
howev
intermedi
stage
basophil
product
definit
identifi
evid
basophil
may
share
common
precursor
eosinophil
mast
cell
megakaryocyt
radin
wellman
arock
et
al
stimul
play
major
role
termin
differenti
basophil
gmcsf
also
play
role
basophil
differenti
arock
et
al
mayer
et
al
also
evid
stem
cell
factor
scf
stimul
basophil
differenti
pohlman
favr
et
al
studi
mice
shown
normal
blood
basophil
count
may
maintain
absenc
requir
role
basophil
product
appar
lantz
et
al
specif
factor
lead
termin
differenti
identifi
basophil
lineag
basophil
differenti
may
fact
repres
default
leukocyt
differenti
pathway
arock
et
al
blood
basophil
distribut
circul
margin
pool
similar
granulocyt
circul
halflif
basophil
short
h
rapidli
migrat
tissu
much
longer
surviv
week
hirai
et
al
pohlman
basophil
least
numer
leukocyt
blood
health
usual
compos
approxim
less
blood
leukocyt
differenti
pohlman
galli
et
al
autom
hematolog
analyz
differenti
may
provid
low
estim
actual
blood
basophil
count
human
flow
cytometr
method
may
provid
accur
estim
meintker
et
al
amundsen
et
al
ducrest
et
al
autom
hematolog
analyz
count
dog
cat
demonstr
inaccur
pohlman
tvedten
tvedten
howev
basophil
rabbit
appear
detect
autom
method
due
evid
low
inaccur
basophil
count
human
dog
cat
unclear
accur
autom
basophil
count
nonhuman
primat
rodent
use
nonclin
toxicolog
studi
increas
basophil
count
basophilia
inflamm
increas
blood
basophil
count
may
associ
inflammatori
stimuli
although
decreas
basophil
count
commonli
observ
galli
et
al
increas
basophil
count
associ
infecti
allerg
paraneoplast
inflammatori
condit
parasit
rel
frequent
caus
inflammatori
increas
basophil
count
almost
alway
observ
conjunct
increas
blood
eosinophil
count
mani
endoparasit
predominantli
helminth
tissu
exposur
migrat
ectoparasit
includ
varieti
arthropod
associ
concurr
increas
eosinophil
basophil
count
schultz
pohlman
voehring
falcon
et
al
brown
rosalski
roth
levi
ogilvi
et
al
infecti
agent
parasit
also
report
caus
increas
basophil
count
sever
viral
etiolog
associ
increas
basophil
count
human
includ
influenza
chickenpox
smallpox
virus
galli
et
al
sever
bacteri
infect
may
also
caus
increas
blood
basophil
count
includ
tuberculosi
galli
et
al
infect
helicobact
pylori
karttunen
et
al
allerg
inflamm
involv
ige
andor
caus
increas
eosinophil
count
typic
also
caus
increas
blood
basophil
count
immedi
delay
hypersensit
may
caus
increas
basophil
count
although
immedi
hypersensit
also
associ
decreas
basophil
count
case
whether
basophil
count
increas
decreas
may
repres
distinct
allerg
sensit
immedi
allerg
reaction
shelley
parn
food
inhal
allergi
ragwe
pollen
otsuka
et
al
frequent
caus
increas
blood
basophil
count
galli
et
al
pohlman
allerg
inflamm
also
occur
insect
sting
bite
stockham
scott
probabl
h
pylori
infect
karttunen
et
al
paraneoplast
increas
basophil
count
associ
sever
neoplast
process
includ
dissemin
mast
cell
neoplasia
schultz
stockham
scott
carcinoma
galli
et
al
increas
blood
basophil
count
may
also
observ
lymphomatoid
granulomatosi
schultz
stockham
scott
myeloprolif
neoplasm
includ
polycythemia
vera
essenti
thrombocythemia
primari
myelofibrosi
galli
et
al
stockham
scott
miscellan
caus
inflammatori
increas
blood
basophil
count
includ
ulcer
coliti
juhlin
system
mast
cell
disord
urticaria
pigmentosa
asboehansen
juvenil
rheumatoid
arthriti
athreya
et
al
immunolog
respons
caus
acut
reject
tissu
graft
tikkanen
et
al
endocrinopathi
sever
endocrinopathi
associ
increas
blood
basophil
count
endocrinopathi
includ
hypothyroid
myxedema
diabet
mellitu
galli
et
al
shelley
parn
suggest
increas
basophil
count
secondari
hyperlipidemia
associ
endocrinopathi
support
mechanist
evid
scant
pohlman
schultz
neoplasia
although
rel
rare
chronic
myelogen
leukemia
frequent
associ
increas
blood
basophil
count
spier
et
al
blood
basophil
demonstr
cytogenet
analysi
aris
neoplast
clone
goh
anderson
howev
suggest
chronic
basophil
leukemia
may
separ
process
basophil
chronic
myeloid
granulocyt
leukemia
pardanani
et
al
chronic
leukemia
associ
clonal
increas
blood
basophil
count
also
potenti
undergo
blast
transform
acut
basophil
leukemia
may
also
occur
rare
duchayn
et
al
form
acut
myelogen
leukemia
may
also
associ
increas
basophil
count
galli
et
al
xenobioticinduc
administr
gcsf
gmcsf
may
caus
modest
increas
blood
basophil
count
along
pronounc
increas
neutrophil
eosinophil
count
stimul
granulocyt
product
administr
phenylhydrazin
rat
model
hemolysi
associ
increas
blood
leukocyt
count
includ
basophil
count
criswel
et
al
perhap
common
xenobioticinduc
increas
blood
basophil
count
occur
hypersensit
allerg
reaction
report
includ
associ
administr
heparin
penicillin
novobiocin
schultz
shelley
lower
refer
limit
histor
control
data
common
laboratori
speci
may
includ
basophil
count
cell
ml
due
normal
low
blood
basophil
count
health
decreas
basophil
count
may
detect
recogniz
howev
follow
section
list
condit
decreas
basophil
count
report
glucocorticoidinduc
increas
glucocorticoid
concentr
particularli
prolong
caus
decreas
blood
basophil
count
shelley
parn
juhlin
boseila
similar
glucocorticoidinduc
decreas
eosinophil
count
like
shift
blood
basophil
circul
margin
pool
also
evid
glucocorticoid
caus
migrat
basophil
circul
tissu
decreas
recircul
tissu
back
blood
wald
et
al
direct
lytic
effect
blood
tissu
basophil
suppress
basophil
product
bone
marrow
may
also
contribut
boseila
myocardi
infarct
associ
decreas
blood
basophil
count
may
mediat
effect
chronic
stress
secondari
ischem
event
juhlin
inflamm
hypersensit
sever
acut
overwhelm
inflamm
lead
decreas
basophil
count
along
decreas
blood
leukocyt
count
relationship
endotoxemia
decreas
basophil
count
support
reduct
blood
basophil
count
rabbit
administ
endotoxin
salmonella
typhi
goncharova
krylova
also
inflammatori
leukocytosi
associ
overwhelm
inflamm
often
associ
decreas
basophil
count
galli
et
al
type
hypersensit
reaction
mediat
rapid
ige
releas
commonli
associ
decreas
eosinophil
basophil
count
howev
type
iv
hypersensit
cellmedi
caus
histamin
releas
mast
cell
may
also
associ
decreas
basophil
count
hypersensitivityrel
decreas
basophil
count
observ
anaphylaxi
urticaria
galli
et
al
grattan
et
al
grattan
et
al
shelley
juhlin
hyperthyroid
thyrotoxicosi
report
caus
decreas
blood
basophil
count
shelley
parn
juhlin
howev
mechan
decreas
clearli
demonstr
exogen
administr
glucocorticoid
result
decreas
blood
basophil
count
similar
decreas
caus
endogen
glucocorticoid
also
administr
thyroid
hormon
thyroid
stimul
hormon
healthi
individu
report
caus
decreas
blood
basophil
count
consist
decreas
basophil
count
observ
natur
occur
hyperthyroid
boseila
acut
hypersensit
reaction
xenobiot
may
caus
decreas
blood
basophil
count
xenobioticinduc
urticaria
angioedema
anaphylact
reaction
igemedi
type
hypersensit
reaction
associ
angiotensinconvert
enzym
ace
inhibitor
variou
nsaid
roujeau
due
igemedi
natur
reaction
xenobiot
would
potenti
caus
concurr
decreas
blood
basophil
count
although
igerel
increas
basophil
count
could
also
occur
describ
previous
menthol
also
associ
urticaria
decreas
basophil
count
papa
shelley
decreas
blood
basophil
count
may
also
occur
along
decreas
leukocyt
count
associ
xenobioticinduc
bone
marrow
suppress
aplast
anemia
class
chemotherapeut
agent
may
caus
bone
marrow
suppress
result
decreas
multipl
leukocyt
lineag
blood
includ
basophil
xenobiot
implic
caus
aplast
anemia
includ
chloramphenicol
anticonvuls
phenytoin
carbamazepin
goldbas
compound
penicillamin
phenylbutazon
bloom
brandt
kaufman
et
al
autom
hematolog
analyz
siemen
healthcar
advia
system
includ
larg
unclassifi
cell
luc
cell
categori
leukocyt
differenti
cell
gener
larg
minim
myeloperoxidas
activ
fall
within
predefin
speci
gate
paramet
typic
identifi
leukocyt
subtyp
cell
repres
distinct
cell
type
commonli
larg
andor
reactiv
lymphocyt
monocyt
increas
luc
count
may
observ
condit
result
increas
blood
lymphocyt
monocyt
count
speci
autom
basophil
count
reliabl
increas
blood
basophil
count
may
also
appear
increas
luc
count
acut
leukemia
typifi
increas
hematopoiet
blast
cell
bone
marrow
circul
almost
alway
result
increas
luc
count
presenc
high
luc
count
blood
smear
evalu
perform
assess
leukocyt
differenti
morpholog
appear
blood
leukocyt
occasion
may
mast
cell
observ
blood
smear
dog
cat
laboratori
rodent
mast
cell
blood
mastocytemia
typic
occur
low
number
significantli
affect
autom
leukocyt
differenti
mastocytemia
may
occur
along
inflammatori
respons
howev
system
mastocytosi
mast
cell
leukemia
may
caus
notabl
increas
blood
mast
cell
mast
cell
neoplasia
common
caus
circul
mast
cell
cat
skeldon
et
al
blood
smear
evalu
requir
enumer
mast
cell
part
leukocyt
differenti
earliest
erythrocyt
product
primit
erythropoiesi
occur
yolk
sac
initi
eventu
also
liver
fetal
develop
later
fetal
develop
erythrocyt
product
switch
predominantli
bone
marrow
consid
definit
erythropoiesi
harvey
neonat
foci
extramedullari
hematopoiesi
may
observ
within
liver
histolog
rat
mice
erythropoiesi
within
spleen
often
significantli
contribut
mainten
normal
blood
erythrocyt
content
increas
erythropoiesi
speci
may
accompani
increas
extramedullari
hematopoiesi
spleen
without
appreci
chang
bone
marrow
observ
histolog
increas
splenic
hematopoiesi
speci
may
suffici
caus
detect
chang
organ
weight
valu
erythropoiesi
larg
control
stimul
erythropoietin
epo
although
stem
cell
factor
scf
thrombopoietin
tpo
may
also
play
role
earli
erythrocyt
differenti
insulinlik
growth
factor
igf
may
contribut
later
erythropoiesi
olver
erythrocyt
differenti
begin
pluripot
hematopoiet
stem
cell
differenti
common
myeloid
progenitor
cell
differenti
megakaryocyteerythrocyt
progenitor
cell
stimul
epo
megakaryocyteerythrocyt
progenitor
differenti
first
commit
erythroid
progenitor
burstform
unit
erythrocyt
bfue
differenti
colonyform
unit
erythrocyt
cfue
precursor
next
stage
erythroid
develop
rubriblast
earliest
erythroid
progenitor
may
identifi
light
microscopi
erythroid
cell
matur
progress
prorubricyt
basophil
rubricyt
polychromatophil
rubricyt
metarubricyt
stage
stage
progress
nuclear
chromatin
becom
condens
nucleu
becom
pyknot
coincid
increas
hemoglobin
product
accumul
within
cytoplasm
simultan
decreas
rna
product
point
pyknot
nuclei
extrud
cell
form
reticulocyt
releas
bone
marrow
prolif
bone
marrow
erythrocyt
pool
includ
rubriblast
basophil
rubricyt
matur
bone
marrow
erythrocyt
pool
includ
polychromatophil
rubricyt
reticulocyt
reticulocyt
may
matur
erythrocyt
either
spleen
blood
sometim
reticulocyt
matur
erythrocyt
may
contain
small
remnant
fragment
nuclei
call
howelljolli
bodi
may
observ
low
number
circul
passag
blood
spleen
typic
result
remov
speci
sinusoid
splenic
architectur
cat
nonsinusoid
splenic
architectur
less
effici
remov
howelljolli
bodi
circul
erythrocyt
howelljolli
bodi
may
observ
healthi
cat
speci
occasion
metarubricyt
may
also
releas
bone
marrow
observ
circul
although
nucleu
extrus
typic
occur
splenic
passag
cell
also
splenic
reticuloendotheli
system
major
role
remov
damag
senesc
erythrocyt
circul
major
role
erythrocyt
carri
oxygen
bind
hemoglobin
lung
tissu
alter
tissu
demand
oxygen
increas
decreas
product
epo
therefor
erythropoiesi
adult
epo
produc
kidney
respons
hypoxia
circul
blood
volum
compos
erythrocyt
bloom
brandt
usual
mani
noncircul
erythrocyt
present
within
splenic
red
pulp
autom
hematolog
analyz
provid
indic
blood
erythrocyt
count
blood
hemoglobin
concentr
hematocrit
collect
indic
red
cell
mass
health
vast
major
blood
erythrocyt
matur
erythrocyt
small
proport
reticulocyt
except
rodent
rodent
normal
mildli
greater
reticulocyt
count
rel
common
laboratori
speci
due
higher
erythrocyt
turnov
gerbil
tend
shortest
erythrocyt
lifespan
therefor
highest
reticulocyt
count
erythrocyt
lifespan
circul
speciesdepend
human
erythrocyt
averag
lifespan
day
thiagarajan
prchal
macaqu
erythrocyt
lifespan
approxim
day
provench
bollig
et
al
canin
felin
erythrocyt
lifespan
approxim
day
respect
stockham
scott
contrast
rat
erythrocyt
estim
lifespan
approxim
day
van
putten
croon
although
strainrel
variabl
derelanko
mous
erythrocyt
lifespan
even
shorter
estim
day
van
putten
croon
mongolian
gerbil
erythrocyt
lifespan
estim
day
classic
pattern
alter
red
blood
cell
paramet
summar
tabl
rel
increas
red
cell
mass
hemoconcentr
commonli
occur
due
dehydr
splenic
contract
contrast
absolut
true
increas
red
cell
mass
result
prolifer
erythroid
precursor
bone
marrow
andor
spleen
rel
increas
transient
consist
chang
total
blood
volum
shift
noncircul
erythrocyt
circul
result
increas
red
cell
mass
rapidli
resolv
dehydr
dehydr
rel
common
caus
secondari
increas
red
cell
mass
dehydr
result
deplet
water
content
blood
rel
increas
blood
compon
includ
cell
hemoconcentr
due
high
number
erythrocyt
present
increas
red
cell
mass
detect
wherea
increas
leukocyt
subtyp
often
observ
increas
red
cell
mass
usual
observ
conjunct
increas
urea
nitrogen
andor
creatinin
preren
azotemia
concurr
decreas
urin
volum
increas
urin
specif
graviti
well
proport
increas
albumin
globulin
evalu
plasma
fibrinogen
may
also
increas
nonclin
toxicolog
studi
rodent
decreas
food
consumpt
often
associ
concurr
decreas
water
intak
result
increas
red
cell
mass
subclin
clinic
dehydr
resolut
secondari
increas
red
cell
mass
occur
adequ
rehydr
catecholamineinduc
increas
circul
catecholamin
level
respons
fright
excit
acut
stress
result
increas
red
cell
mass
due
splenic
contract
noncircul
erythrocyt
store
within
red
pulp
spleen
expel
result
increas
circul
red
cell
mass
increas
red
cell
mass
transient
resolv
splenic
relax
occur
follow
declin
circul
catecholamin
level
catecholamineinduc
splenic
contractionassoci
rel
increas
red
cell
mass
commonli
observ
pretest
collect
nonclin
toxicolog
studi
util
nonhuman
primat
dog
cat
particularli
first
pretest
collect
multipl
collect
perform
typic
observ
subsequ
collect
anim
becom
acclim
hous
handlingrestraint
phlebotomi
studyrel
procedur
xenobioticrel
caus
rel
increas
red
cell
mass
rel
uncommon
except
dehydr
associ
decreas
food
consumpt
rodent
util
nonclin
toxicolog
studi
describ
earlier
diuret
furosemid
spironolacton
result
increas
elimin
water
urin
may
result
hemoconcentr
due
dehydr
mintzer
et
al
secondari
increas
red
cell
mass
depend
stimul
factor
autonom
contrast
primari
increas
red
cell
mass
secondari
increas
red
cell
mass
commonli
associ
increas
epo
concentr
due
hypoxia
therefor
consid
appropri
howev
hypoxiaindepend
inappropri
mechan
may
also
caus
secondari
increas
red
cell
mass
also
describ
later
hypoxiadepend
appropri
increas
epo
product
occur
respons
hypoxia
primarili
kidney
although
also
evid
hypoxia
may
also
stimul
product
epo
liver
rankin
et
al
normal
oxygen
state
hypoxiainduc
factor
hif
subunit
polyubiquitin
von
hipplelindau
vhl
tumor
suppressor
ligas
complex
result
proteosom
degrad
hif
jaakkola
et
al
bind
vhl
ligas
complex
hif
requir
hydroxyl
prolin
residu
vhl
protein
process
requir
oxygen
iron
ivan
et
al
hypox
state
hif
ubiquitin
hif
subunit
transloc
nucleu
form
transcript
factor
gene
includ
erythropoietin
gene
increas
circul
epo
concentr
result
hypoxia
caus
magnitud
reticulocyt
count
increas
gener
reflect
magnitud
red
cell
mass
decreas
decreas
red
cell
mass
initi
preregen
without
appar
increas
reticulocyt
count
b
overwhelm
intravascular
hemolysi
caus
increas
plasma
serum
free
hemoglobin
mchc
may
artifactu
increas
mchc
commonli
decreas
due
increas
reticulocyt
count
c
increas
plasma
serum
free
hemoglobin
expect
occur
overwhelm
intravascular
hemolysi
chronic
iron
defici
anemia
typic
nonregen
decreas
reticulocyt
count
increas
reticulocyt
count
may
observ
follow
transfus
iron
supplement
pattern
describ
tabl
indic
classic
expect
chang
red
blood
cell
compon
associ
endpoint
due
process
howev
durat
process
variat
underli
caus
condit
superimposit
multipl
process
may
result
differ
expect
pattern
leukocyt
chang
actual
chang
observ
individu
appropri
increas
erythropoiesi
subsequ
increas
red
cell
mass
improv
deliveri
oxygen
tissu
sustain
tissu
hypoxia
result
high
altitud
resid
cardiac
diseas
caus
poor
tissu
lung
perfus
prolong
chronic
pulmonari
diseas
impair
oxygen
copd
secondari
chronic
smoke
obstruct
sleep
apnea
human
prchal
stockham
scott
condit
may
caus
hypoxiainduc
increas
red
cell
mass
includ
mutat
lead
hemoglobin
high
affin
oxygen
carboxyhemoglobin
format
heavi
smoke
erythrocyt
enzym
defici
lead
methemoglobinemia
cytochrom
b
reductas
defici
may
also
result
hypoxiainduc
increas
red
cell
mass
prchal
erythrocyt
enzym
defici
result
methemoglobinemia
report
veterinari
speci
stockham
scott
hemoglobinopathi
condit
character
abnorm
hemoglobin
yet
report
domest
anim
randolph
et
al
hypoxiaindepend
inappropri
secondari
hypoxiaindepend
increas
red
cell
mass
associ
increas
circul
epo
level
howev
increas
epo
case
attribut
autonom
product
epo
rather
hypoxia
respons
report
associ
includ
renal
diseas
renal
nonren
neoplasm
rare
dysfunct
oxygen
sens
pathway
nonneoplas
renal
diseas
associ
increas
epo
product
includ
hydronephrosi
renal
cyst
polycyst
renal
diseas
prchal
renal
diseas
may
associ
local
tissu
hypoxia
randolph
et
al
associ
system
hypoxia
similarli
increas
red
cell
mass
may
observ
human
follow
renal
transplant
prchal
autonom
product
epo
neoplasm
associ
benign
malign
tumor
renal
adenoma
renal
carcinoma
sarcoma
kidney
report
caus
increas
red
cell
mass
way
et
al
renal
lymphoma
also
associ
increas
red
cell
mass
durno
et
al
nonren
tumor
inappropri
epo
product
includ
hepatoma
hamartoma
liver
leiomyosarcoma
schwannoma
pheochromocytoma
stockham
scott
levgur
levi
muta
et
al
shulkin
et
al
joseph
et
al
vhl
syndrom
follow
autosom
domin
pattern
inherit
may
predispos
affect
peopl
develop
renal
nonren
neoplasm
autonom
produc
epo
prchal
also
rare
inherit
condit
caus
defect
oxygen
sens
pathway
describ
human
includ
chuvash
polycythemia
follow
autosom
recess
inherit
pattern
gene
mutat
caus
defici
prolin
hydroxylas
prchal
high
cobalt
concentr
may
also
inhibit
oxygen
sens
pathway
prevent
bind
vhl
ligas
hif
yuan
et
al
schuster
et
al
increas
red
cell
mass
associ
endocrinopathi
gener
mild
result
overt
clinic
sign
hyperthyroid
caus
sustain
increas
tissu
demand
oxygen
lead
hypoxia
increas
epo
product
consequ
increas
red
cell
mass
stockham
scott
acromegali
caus
increas
growth
hormon
concentr
also
associ
increas
red
cell
mass
particularli
cat
randolph
et
al
hyperadrenocortic
adren
neoplasm
produc
androgen
aldosteron
may
also
associ
increas
red
cell
mass
prchal
ghio
et
al
mann
et
al
xenobioticinduc
increas
red
cell
mass
uncommon
administr
recombin
erythropoietin
anabol
steroid
report
caus
increas
red
cell
mass
mintzer
et
al
exampl
increas
red
cell
mass
associ
testosteron
administr
gardner
et
al
theoret
excess
administr
thyroid
hormon
could
also
caus
increas
red
cell
mass
primari
erythropoietinindepend
increas
red
cell
mass
associ
myelodysplast
condit
autonom
product
erythrocyt
due
autonom
natur
prolifer
primari
increas
red
cell
mass
also
term
inappropri
depend
epo
stimul
caus
common
secondari
increas
red
cell
mass
exclud
prior
diagnosi
primari
increas
red
cell
mass
measur
epo
concentr
may
use
clinic
peopl
assay
quantifi
epo
readili
avail
veterinari
speci
primari
increas
red
cell
mass
uncommon
typic
observ
common
laboratori
speci
nonclin
toxicolog
studi
polycythemia
vera
polycythemia
vera
categor
chronic
myeloprolif
disord
neoplast
transform
acquir
somat
mutat
prchal
hematopoiet
progenitor
cell
result
clonal
autonom
expans
hematopoiet
cell
includ
erythrocyt
eventu
clonal
expans
suffici
suppress
normal
hematopoiesi
increas
red
cell
mass
prototyp
find
concurr
increas
leukocyt
platelet
count
aris
neoplast
clone
often
also
observ
peopl
pearson
although
find
typic
observ
dog
cat
randolph
et
al
common
caus
somat
mutat
polycythemia
vera
human
mutat
kinas
play
role
intracellular
prolif
signal
prchal
howev
form
polycythemia
vera
idiopath
erythrocytosi
without
mutat
observ
associ
mutat
lymphocytespecif
adaptor
protein
lnk
inhibit
phosphoryl
lasho
et
al
serum
epo
concentr
expect
low
patient
polycythemia
vera
domest
dog
cat
middleag
femal
dog
male
cat
tend
commonli
affect
randolph
et
al
primari
famili
congenit
polycythemia
similar
polycythemia
vera
primari
famili
congenit
polycythemia
pfcp
also
caus
autonom
erythroid
prolifer
despit
low
serum
epo
howev
pfcp
associ
nonclon
erythroid
prolifer
inherit
mutat
autosom
domin
pattern
inherit
prchal
et
al
identifi
mutat
definit
associ
pfcp
result
truncat
epo
receptor
loss
neg
regulatori
domain
caus
constitut
activ
signal
pathway
promot
erythrocyt
prolifer
decreas
red
cell
mass
anemia
rel
common
find
human
common
laboratori
speci
decreas
red
cell
mass
categor
concurr
chang
reticulocyt
count
provid
indic
bone
marrow
respons
may
help
differenti
among
possibl
mechan
decreas
red
cell
mass
concurr
increas
reticulocyt
count
indic
regen
erythroid
bone
marrow
respons
normal
low
reticulocyt
count
may
repres
preregen
suppress
ineffect
erythroid
respons
decreas
red
cell
mass
concurr
increas
reticulocyt
count
reticulocytosi
indic
regen
erythroid
respons
bone
marrow
extramedullari
hematopoiesi
spleen
rodent
increas
reticulocyt
count
typic
first
observ
day
acut
drop
red
cell
mass
due
bone
marrow
erythrocyt
product
transit
time
peak
respons
gener
occur
around
day
depend
speci
stockham
scott
regen
erythroid
respons
consid
appropri
increas
reticulocyt
count
reflect
magnitud
decreas
red
cell
mass
word
mild
decreas
red
cell
mass
expect
result
mild
increas
reticulocyt
count
moder
mark
decreas
red
cell
mass
concurr
moder
mark
increas
reticulocyt
count
regen
erythroid
respons
consid
inappropri
inconsist
magnitud
decreas
red
cell
mass
magnitud
increas
reticulocyt
count
exampl
mark
decreas
red
cell
mass
mild
increas
reticulocyt
count
week
insult
would
consid
inappropri
regen
erythroid
respons
increas
blood
reticulocyt
count
may
associ
concurr
chang
mean
corpuscular
volum
mcv
indic
erythrocyt
size
mean
corpuscular
hemoglobin
concentr
mchc
indic
erythrocyt
hemoglobin
content
two
red
blood
cell
indic
provid
autom
hematolog
analyz
due
reticulocyt
increas
volum
rel
matur
erythrocyt
increas
blood
reticulocyt
count
may
caus
increas
mcv
macrocytosi
decreas
mchc
hypochromasia
regen
anemia
increas
mcv
decreas
mchc
andor
chcm
may
also
classifi
indic
macrocyt
hypochrom
anemia
decreas
mchc
necessarili
reflect
less
hemoglobin
content
per
cell
consequ
reduc
concentr
hemoglobin
due
larger
cytoplasm
volum
reticulocyt
mchc
calcul
endpoint
may
artifici
increas
free
plasma
hemoglobin
present
due
intravascular
hemolysi
autom
hematolog
analyz
also
provid
corpuscular
mean
hemoglobin
content
chcm
provid
mean
direct
measur
cellular
hemoglobin
concentr
therefor
resist
interfer
free
plasma
hemoglobin
regen
erythroid
respons
increas
blood
reticulocyt
count
may
associ
sever
morpholog
find
observ
blood
smear
evalu
commonli
increas
polychromatophil
polychromasia
observ
wrightgiemsa
modifi
wright
stain
polychromatophil
erythrocyt
stain
bluepurpl
color
due
combin
effect
bluestain
rna
content
typic
reticulocyt
pinkstain
hemoglobin
reticulocyt
matur
lose
rna
visual
differ
stain
longer
detect
late
reticulocyt
matur
erythrocyt
howev
stain
blood
vital
dye
new
methylen
blue
permit
differenti
aggreg
punctatetyp
reticulocyt
polychromasia
usual
correl
well
increas
reticulocyt
speci
except
cat
stockham
scott
cat
aggregatetyp
punctatetyp
reticulocyt
correl
polychromasia
consid
clinic
relev
differenti
two
manual
reticulocyt
count
perform
harvey
stockham
scott
reticulocyt
erythrocyt
small
punctat
dark
bluegray
inclus
may
observ
regen
erythroid
respons
inclus
contain
iron
may
call
pappenheim
bodi
siderot
inclus
due
rapid
product
releas
erythrocyt
regen
erythroid
respons
may
also
increas
nucleat
red
blood
cell
erythrocyt
howelljolli
bodi
nucleat
red
blood
cell
usual
present
low
number
observ
per
leukocyt
autom
total
leukocyt
count
fals
increas
correct
use
publish
equat
stockham
scott
speci
particularli
cow
sheep
erythrocyt
basophil
stippl
may
also
observ
circul
regen
erythroid
respons
hemolysi
blood
loss
two
main
categori
decreas
red
cell
mass
appropri
increas
reticulocyt
count
destruct
matur
erythrocyt
call
hemolysi
hemolysi
may
occur
either
intravascularli
extravascularli
intravascular
hemolysi
erythrocyt
destruct
occur
within
blood
result
hemoglobinemia
free
hemoglobin
within
plasma
ghost
erythrocyt
remnant
membran
erythrocyt
longer
contain
cytoplasm
hemoglobin
may
observ
intravascular
hemolysi
consequ
hemoglobinuria
free
hemoglobin
urin
rare
occur
case
massiv
intravascular
hemolysi
overwhelm
normal
pathway
clear
free
hemoglobin
blood
contrast
extravascular
hemolysi
occur
within
blood
rather
occur
spleen
liver
bone
marrow
resid
macrophag
phagocytos
erythrocyt
destroy
intracellularli
extravascular
hemolysi
result
free
plasma
hemoglobin
hemoglobinuria
type
hemolysi
may
associ
increas
total
bilirubin
concentr
unconjug
indirect
bilirubin
usual
exce
conjug
direct
bilirubin
may
result
plasma
serum
icteru
yellow
discolor
bilirubinuria
bilirubin
present
urin
howev
case
hemolysi
clearli
either
intravascular
extravascular
form
hemolysi
may
contribut
condit
infecti
numer
protozo
bacteri
viral
diseas
associ
hemolysi
mechan
infecti
agent
caus
erythrocyt
destruct
vari
may
includ
direct
infect
erythrocyt
elabor
toxin
hemolysin
stimul
immunemedi
respons
infect
cell
berkowitz
sever
exampl
infecti
agent
caus
hemolyt
anemia
discuss
later
direct
infect
erythrocyt
protozo
plasmodium
speci
caus
agent
malaria
transmit
mosquito
rel
common
caus
hemolysi
human
may
also
observ
nonhuman
primat
use
nonclin
toxicolog
studi
human
infect
one
five
differ
plasmodium
speci
p
falciparum
p
vivax
p
knowlesi
p
malaria
p
oval
although
p
falciparum
p
vivax
commonli
associ
sever
hemolysi
lichtman
macaqu
commonli
infect
p
inui
p
knowlesi
although
cynomolgu
monkey
appear
resist
diseas
infect
rhesu
monkey
ameri
infect
p
cynomolgi
p
fieldi
p
fragil
may
also
occur
macaqu
magden
et
al
although
uncommon
includ
macaqu
infect
plasmodium
speci
nonclin
toxic
studi
due
current
screen
practic
pretest
evalu
rare
anim
decreas
red
cell
mass
increas
reticulocyt
count
intraerythrocyt
plasmodium
organ
observ
rat
mice
may
infect
plasmodium
berghei
holloway
et
al
sadun
et
al
plasmodium
berghei
specif
tropism
reticulocyt
rather
matur
erythrocyt
plasmodium
speci
infect
human
car
et
al
cromer
et
al
concurr
increas
reticulocyt
count
may
occur
earli
stage
diseas
recrudesc
parasitemia
hemolysi
hemolysi
associ
clearanc
parasit
erythrocyt
circul
predominantli
splenic
macrophag
lichtman
although
accumul
hemin
ironcontain
porphyrin
directli
stimul
apoptot
erythrocyt
death
eryptosi
gatidi
et
al
oxid
damag
erythrocyt
membran
clark
hunt
increas
osmot
fragil
georg
et
al
may
contribut
hemolysi
howev
latestag
infect
human
rodent
also
associ
inappropri
decreas
reticulocyt
count
indic
suppress
erythropoiesi
despit
decreas
red
cell
mass
hemolysi
lichtman
cromer
et
al
babesia
speci
tickborn
protozo
organ
directli
infect
erythrocyt
speci
includ
human
nonhuman
primat
dog
cat
babesia
speci
appear
intracellular
oval
pyriform
organ
babesia
microti
babesia
divergen
may
infect
human
north
america
europ
respect
caus
moder
hemolyt
anemia
intraerythrocyt
replic
subsequ
erythrocyt
lysi
lichtman
kjemtrup
conrad
babesia
pitheci
report
infect
old
new
world
monkey
caus
anemia
magden
et
al
b
cani
larg
babesi
speci
b
gibsoni
small
babesi
speci
infect
dog
cat
may
infect
small
babesi
organ
b
feli
b
cati
stockham
scott
penzhorn
et
al
organ
gener
concern
purposebr
anim
use
nonclin
toxicolog
studi
bartonella
bacilliformi
peopl
hemotroph
mycoplasma
hemoplasma
dog
cat
formerli
haemobartonella
speci
swine
formerli
eperythrozoon
speci
organ
parasit
erythrocyt
organ
remain
extracellular
shallow
depress
erythrocyt
membran
organ
typic
round
rod
ringshap
may
observ
individu
chain
erythrocyt
surfac
hemolysi
organ
may
immunemedi
associ
either
bind
antibodi
parasit
antigen
antigen
expos
erythrocyt
secondari
parasiteinduc
membran
chang
stockham
scott
clostridium
perfringen
formerli
clostridium
welchii
infect
human
exampl
bacteri
caus
hemolysi
intestin
overgrowth
septicemia
c
perfringen
type
elabor
toxin
lecithinas
c
activ
result
membran
phospholipid
breakdown
releas
lysolethicin
potent
hemolyt
capabl
lichtman
songer
c
perfringen
toxin
releas
usual
associ
sever
intravascular
hemolysi
hemoglobinemia
hemoglobinuria
howev
veterinari
speci
c
perfringensrel
hemolysi
typic
limit
rumin
hors
stockham
scott
unlik
observ
common
speci
use
nonclin
toxicolog
studi
infect
human
mycoplasma
pneumonia
also
associ
hemolyt
decreas
red
cell
mass
although
case
pneumonia
infect
asymptomat
hemolysi
organ
attribut
stimul
autoimmun
erythrocyt
destruct
agglutin
erythrocyt
khan
yassin
sever
viral
organ
human
also
report
caus
decreas
red
cell
mass
due
hemolysi
viral
caus
hemolysi
commonli
associ
autoimmun
mechan
includ
infect
epsteinbarr
viru
palanduz
et
al
hepat
b
c
virus
kanematsu
et
al
chao
et
al
cytomegaloviru
murray
et
al
hiv
koduri
et
al
although
hiv
infect
also
commonli
associ
decreas
reticulocyt
count
rather
expect
increas
secondari
hemolysi
indic
concurr
suppress
erythropoiesi
telen
et
al
oxid
anoth
major
caus
decreas
red
cell
mass
due
hemolysi
oxid
damag
erythrocyt
normal
condit
ferrou
iron
fe
hemoglobin
bind
dissoci
oxygen
deliv
oxygen
lung
tissu
time
bind
dissoci
result
format
ferric
iron
fe
hemoglobin
methemoglobin
well
superoxid
superoxid
free
radic
potent
oxid
capac
may
caus
cellular
damag
cytochrom
b
reductas
intraerythrocyt
enzym
convert
methemoglobin
back
hemoglobin
superoxid
dismutas
convert
superoxid
hydrogen
peroxid
h
also
may
produc
oxid
damag
cell
metabol
hydrogen
peroxid
catalas
glutathion
peroxidas
protect
cell
oxid
damag
pathway
usual
suffici
address
normal
lowlevel
format
methemoglobin
superoxid
methemoglobin
increas
impair
deliveri
oxygen
tissu
superoxid
accumul
caus
oxid
damag
pathway
overwhelm
defect
oxid
damag
erythrocyt
may
affect
lipid
membran
cytoskeleton
hemoglobin
peroxid
intern
membran
lipid
cytoskelet
compon
erythrocyt
result
fusion
portion
membran
consequ
shift
cytoplasm
hemoglobin
one
side
cell
erythrocyt
morpholog
chang
call
eccentrocyt
oxid
damag
caus
format
eccentrocyt
may
result
hemolysi
due
increas
clearanc
eccentrocyt
splenic
macrophag
due
trap
rigid
erythrocyt
splenic
sinusoid
spontan
ruptur
blood
due
increas
fragil
eccentrocyt
stockham
scott
oxid
damag
expos
cystein
sulfhydryl
group
hemoglobin
result
hemoglobin
denatur
decreas
solubl
bloom
brandt
denatur
hemoglobin
may
precipit
aggreg
within
erythrocyt
form
small
palestain
round
structur
bind
erythrocyt
membran
tend
protrud
surfac
erythrocyt
aggreg
denatur
hemoglobin
call
heinz
bodi
cat
appear
particularli
sensit
format
heinz
bodi
increas
number
reactiv
sulfhydryl
group
hemoglobin
rel
speci
christoph
et
al
may
rapidli
observ
blood
smear
evalu
due
nonsinusoid
architectur
felin
spleen
result
decreas
clearanc
heinz
bodi
circul
similar
eccentrocyt
erythrocyt
heinz
bodi
may
undergo
hemolysi
due
increas
clearanc
splenic
macrophag
follow
trap
splenic
sinusoid
due
decreas
erythrocyt
deform
spontan
ruptur
due
increas
fragil
membran
damag
immunemedi
clearanc
may
also
occur
believ
result
bind
hemochrom
subsequ
redistribut
band
erythrocyt
membran
structur
protein
may
recogn
autolog
antibodi
winterbourn
mani
condit
may
caus
oxid
damag
result
eccentrocytosi
heinz
bodi
format
even
simultan
diabet
mellitu
may
caus
either
morpholog
chang
diabet
ketoacidosi
appear
associ
increas
suscept
incid
oxid
erythrocyt
damag
desnoy
caldin
et
al
christoph
et
al
inherit
defici
erythrocyt
dehydrogenas
flavin
adenin
dinucleotid
fad
also
associ
erythrocyt
oxid
damag
eccentrocyt
heinz
bodi
format
hemolysi
predisposit
event
due
loss
protect
antioxid
pathway
chan
et
al
harvey
lymphoma
also
associ
heinz
bodi
format
cat
christoph
eccentrocyt
format
dog
caldin
et
al
dog
cat
ingest
allium
speci
particularli
onion
garlic
chines
chive
may
caus
erythrocyt
oxid
damag
format
eccentrocyt
andor
heinz
bodi
caldin
et
al
yamato
et
al
robertson
et
al
ingest
zinc
dog
bexfield
et
al
exposur
skunk
musk
fierro
et
al
also
report
caus
hemolysi
due
heinz
bodi
format
fragment
physic
trauma
erythrocyt
result
hemolysi
due
erythrocyt
fragment
lysi
sometim
type
hemolysi
refer
microangiopath
hemolyt
anemia
morpholog
chang
erythrocyt
occur
result
physic
trauma
schistocyt
also
call
schizocyt
erythrocyt
fragment
keratocyt
also
call
helmet
cell
prekeratocyt
also
call
blister
cell
even
spherocyt
microspherocyt
may
observ
schistocyt
small
usual
irregularli
shape
fragment
break
erythrocyt
physic
trauma
occur
keratocyt
one
two
variabl
size
project
horn
adjac
small
flatten
region
erythrocyt
surfac
prekeratocyt
appear
precursor
small
loop
erythrocyt
cytoplasm
extend
surfac
surround
small
hole
cell
spherocyt
microspherocyt
spheric
cell
appear
smaller
intens
pinkstain
cytoplasm
normal
matur
erythrocyt
spherocyt
microspherocyt
may
form
physic
trauma
fragment
broken
result
less
membran
surfac
area
parent
erythrocyt
surround
similar
volum
spherocyt
smaller
volum
microspherocyt
parent
erythrocyt
physic
trauma
erythrocyt
caus
fragment
microangiopath
hemolysi
may
result
consumpt
coagulopathi
either
local
dissemin
dic
fibrin
thrombu
format
vasculatur
imped
passag
erythrocyt
vessel
lumen
creat
turbul
physic
obstruct
blood
flow
local
coagulopathi
dic
may
occur
secondari
trauma
infect
sepsi
neoplasia
baker
moak
toh
denni
microangiopath
hemolysi
due
neoplasia
commonli
associ
malign
rather
benign
neoplasm
metastat
diseas
neoplas
emboli
rather
primari
tumor
except
primari
vascular
neoplasm
susano
et
al
kuper
et
al
lohrmann
et
al
infecti
agent
may
also
lead
fragment
erythrocyt
leptospirosi
interrogan
serovar
associ
vascul
stockham
scott
brucella
speci
infect
yarami
et
al
cutan
anthrax
freedman
et
al
report
caus
microangiopath
hemolysi
children
fragment
hemolysi
associ
thrombot
microangiopathi
may
occur
shigella
dysenteria
type
escherichia
coli
infect
pisoni
et
al
hemolysi
erythrocyt
fragment
may
also
occur
hiv
infect
maslo
et
al
decreas
red
cell
mass
increas
reticulocyt
count
erythrocyt
fragment
may
also
occur
secondari
cardiac
condit
alter
hemodynam
increas
turbul
blood
flow
exampl
subaort
stenosi
solanki
sheikh
intralumin
aortic
graft
sayar
et
al
uncorrect
cardiac
valvular
diseas
marsh
lewi
prosthet
valv
crexel
et
al
hypertroph
obstruct
cardiomyopathi
kubo
et
al
report
caus
hemolysi
erythrocyt
fragment
increas
turbul
associ
hypertens
may
also
caus
decreas
red
cell
mass
fragment
associ
pulmonari
hypertens
baker
moak
malign
system
hypertens
capelli
et
al
immunemedi
autoimmun
hemolyt
anemia
aiha
aha
describ
human
immunemedi
hemolyt
anemia
imha
describ
common
laboratori
speci
caus
hemolysi
may
primari
idiopath
may
also
secondari
condit
infect
discuss
previous
primari
idiopath
aiha
imha
discuss
primari
aiha
underli
detect
caus
immunemedi
condit
produc
antibodi
target
erythrocyt
antigen
antierythrocyt
antibodi
tend
specif
singl
erythrocyt
antigen
given
case
packman
autoantibodi
may
classifi
warm
antibodi
usual
igg
cold
antibodi
usual
igm
stockham
scott
immunemedi
aiha
may
associ
erythrocyt
morpholog
chang
includ
agglutin
spherocyt
agglutin
may
observ
grossli
red
speckl
along
insid
specimen
tube
blood
gentli
move
within
tube
agglutin
present
blood
smear
may
revers
smear
appear
densest
region
smear
observ
feather
edg
rather
edg
drop
blood
initi
place
microscop
agglutin
appear
grapelik
cluster
erythrocyt
spherocyt
erythrocyt
spheric
instead
normal
biconcav
disc
shape
spherocyt
appear
smaller
stain
intens
pink
unaffect
matur
erythrocyt
volum
unaffect
erythrocyt
loss
erythrocyt
membran
occur
macrophag
begin
phagocyt
antibodybound
erythrocyt
lead
decreas
erythrocyt
surfac
area
without
appreci
chang
volum
forc
erythrocyt
form
sphere
henc
spherocytosi
alon
result
alter
mcv
common
laboratori
speci
dog
tend
pronounc
central
pallor
normal
matur
erythrocyt
make
microscop
identif
spherocyt
easiest
dog
hemolysi
aiha
larg
attribut
extravascular
hemolysi
due
phagocytosi
antibodybound
erythrocyt
tissu
macrophag
macrophag
monocyt
contain
phagocyt
erythrocyt
may
rare
observ
blood
smear
laboratori
speci
immunemedi
hemolysi
howev
antibodymedi
complement
activ
increas
fragil
spherocyt
may
result
direct
intravascular
lysi
ruptur
erythrocyt
packman
evalu
patient
presenc
antierythrocyt
antibodi
may
perform
use
direct
antiglobulin
test
dat
also
call
coomb
test
flow
cytometri
aiha
rare
observ
associ
lymphoprolif
neoplasia
chronic
lymphocyt
leukemia
antierythrocyt
antibodi
chronic
lymphocyt
leukemia
predominantli
igg
case
igm
report
mauro
et
al
imha
may
occasion
observ
follow
blood
transfus
garratti
may
occur
respons
alloantigen
would
technic
consid
autoimmun
stockham
scott
posttransfus
immunemedi
hemolysi
may
also
observ
host
autoantibodi
bind
donor
erythrocyt
caus
immunemedi
destruct
howev
crossmatch
host
donor
erythrocyt
plasma
abl
prevent
mani
case
incompat
transfusionrel
aiha
aiha
imha
commonli
concurr
inflammatori
increas
leukocyt
subtyp
count
character
mainli
neutrophilia
may
may
left
shift
cytoplasm
chang
indic
rapid
neutropoiesi
inherit
phenotyp
sickl
cell
diseas
associ
hemolysi
mechan
hemolysi
sickl
cell
diseas
like
multifactori
associ
singl
pathogenesi
evid
oxid
damag
erythrocyt
lachant
et
al
may
contribut
hemolysi
observ
sickl
cell
diseas
howev
hemoglobin
polymer
lead
erythrocyt
deform
may
lead
decreas
flexibl
erythrocyt
venoocclus
disord
bookchin
lew
decreas
flexibl
deform
erythrocyt
may
contribut
directli
increas
cell
fragil
ruptur
promot
clearanc
deform
erythrocyt
splenic
macrophag
venoocclus
diseas
potenti
caus
decreas
red
cell
mass
physic
trauma
fragment
howev
also
evid
sever
case
sickl
cell
diseas
may
increas
reticulocyt
count
inappropri
magnitud
decreas
red
cell
mass
suggest
concurr
mechan
caus
suppress
ineffect
erythropoiesi
wu
et
al
bookchin
lew
oxid
stress
erythroid
precursor
may
also
contribut
ineffect
erythropoiesi
sever
case
sickl
cell
diseas
fibach
rachmilewitz
sever
metabol
defect
erythrocyt
metabol
may
also
associ
decreas
red
cell
mass
increas
reticulocyt
count
defici
erythrocyt
pathway
glycolysi
may
result
decreas
atp
concentr
lead
erythrocyt
membran
dysfunct
shorten
erythrocyt
lifespan
occasion
hemolysi
stockham
scott
pyruv
kinas
pk
enzym
catalyz
last
step
aerob
glycolysi
defici
pk
result
hemolysi
report
human
baronciani
beutler
dog
includ
beagl
harvey
et
al
giger
et
al
prass
et
al
breed
cat
kohn
fumi
phosphofructokinas
pfk
catalyz
ratelimit
step
glycolysi
pathway
defici
pfk
also
describ
human
etiembl
et
al
dog
giger
et
al
respiratori
alkalosi
may
observ
follow
intens
exercis
associ
acut
hemolyt
crise
patient
pfk
defici
giger
et
al
associ
inherit
fad
defici
hemolysi
result
oxid
damag
discuss
earlier
brief
fad
play
role
antioxid
pathway
erythrocyt
defici
fad
may
result
increas
oxid
damag
erythrocyt
subsequ
hemolysi
collect
porphyria
group
enzymat
defect
heme
synthesi
pathway
porphyria
may
congenit
commonli
acquir
condit
accumul
porphyrin
precursor
heme
within
erythrocyt
lead
hemolysi
mechan
hemolysi
may
relat
lysi
erythrocyt
follow
exposur
light
photolysi
superfici
vasculatur
direct
erythrocyt
membran
damag
due
lipid
solubl
natur
porphyrin
follow
porphyrin
absorpt
ultraviolet
light
excit
phillip
anderson
kaneko
neoplast
variou
neoplast
condit
may
associ
hemolysi
malign
metastat
neoplasm
primari
vascular
neoplasm
may
result
fragment
hemolysi
physic
trauma
erythrocyt
previous
discuss
howev
neoplast
condit
may
also
rare
associ
phagocytosi
destruct
erythrocyt
hemophagocyt
syndrom
hemophagocyt
syndrom
associ
tcell
lymphoma
gonzalez
et
al
nkcell
leukemia
kobayashi
et
al
hemophagocyt
histiocyt
sarcoma
moor
et
al
variou
hematolog
neoplasia
majlufcruz
et
al
xenobioticinduc
mani
xenobiot
capabl
caus
hemolysi
may
caus
hemolysi
oxid
fragment
immunemedi
mechan
exampl
discuss
mani
agent
caus
oxid
erythrocyt
injuri
contain
aromat
structur
metabol
mostli
commonli
cytochrom
free
radic
bradberri
edward
fuller
overwhelm
normal
protect
antioxid
pathway
erythrocyt
lead
direct
erythrocyt
oxid
injuri
oxid
hemoglobin
sulfhydryl
group
result
methemoglobin
format
specif
aromat
compound
associ
free
radic
format
includ
dapson
phenacetin
anthracyclin
doxorubicin
edward
fuller
coleman
et
al
handa
sato
easley
condon
phenacetin
also
associ
format
heinz
bodi
boelsterli
et
al
dog
cat
acetaminophen
paracetamol
may
metabol
minor
reactiv
metabolit
caus
oxid
damag
erythrocyt
result
hemolysi
format
heinz
bodi
andor
eccentrocyt
although
methemoglobinemia
also
observ
cat
desnoy
wallac
et
al
mariani
fulton
aronson
drobatz
xenobiot
caus
methemoglobinemia
also
caus
indirect
oxid
damag
peroxid
activ
methemoglobin
edward
fuller
case
oxygen
hemoglobin
may
act
peroxidas
caus
metabol
xenobiot
reactiv
compound
caus
erythrocyt
oxid
damag
convers
oxyhemoglobin
methemoglobin
exampl
xenobiot
caus
oxid
damag
mechan
phenylhydrazin
primaquin
edward
fuller
vitamin
k
administr
dog
also
caus
oxid
erythrocyt
damag
mechan
fernandez
et
al
chemic
agent
may
caus
oxid
damag
directli
oxid
hemoglobin
sulfhydryl
group
direct
oxid
erythrocyt
cytoskelet
protein
arsin
ga
predominantli
environment
toxin
appear
mediat
hemolyt
effect
erythrocyt
membran
oxid
rael
et
al
although
studi
mice
also
demonstr
format
heinz
bodi
follow
exposur
blair
et
al
suggest
oxid
effect
hemoglobin
well
mani
xenobiot
may
also
caus
hemolysi
associ
microangiopathi
commonli
part
thrombot
microangiopathi
syndrom
associ
fragment
hemolysi
decreas
platelet
count
druginduc
endotheli
injuri
includ
direct
antibodi
immun
complexmedi
mechan
play
major
role
pathogenesi
thrombot
microangiopathi
pisoni
et
al
endotheli
damag
may
propag
leukocyt
adhes
releas
granul
content
reactiv
oxygen
speci
platelet
activ
aggreg
complement
activ
pisoni
et
al
drug
implic
thrombot
microangiopathi
includ
chemotherapeut
agent
includ
xenobiot
wide
varieti
chemotherapeut
class
exampl
chemotherapeut
associ
thrombot
microangiopathi
includ
mitomycin
c
cantrel
et
al
cisplatin
palmisano
et
al
estramustin
phosphat
tassinari
et
al
gemcitabin
nackaert
et
al
daunorubicin
byrn
et
al
nonchemotherapeut
agent
report
caus
thrombot
microangiopathi
includ
immunomodul
cyclosporin
tacrolimu
katznelson
et
al
trimarchi
et
al
simvastatin
mccarthi
et
al
inhibitor
platelet
aggreg
includ
ticlopidin
clopidogrel
bennett
et
al
immunemedi
mechan
hemolysi
also
report
follow
exposur
numer
xenobiot
xenobiot
may
induc
antibodi
bind
erythrocyt
membran
act
hapten
antibodi
consid
drugdepend
mediat
hemolysi
drug
present
penicillin
prototyp
xenobiot
act
hapten
gener
drugdepend
antibodi
typic
induc
igg
respons
ferner
petz
et
al
semisynthet
penicillin
cephalosporin
tetracyclin
also
report
caus
drugdepend
antibodymedi
hemolysi
garratti
tuff
manoharan
seldon
et
al
et
al
gallagh
et
al
branch
et
al
simpson
et
al
xenobiot
may
also
induc
product
antierythrocyt
antibodi
mediat
hemolysi
even
drug
longer
present
also
call
drugindepend
antibodi
autoantibodi
type
hemolysi
xenobiot
exposur
stimul
product
antibodi
bind
nativ
erythrocyt
antigen
even
absenc
drug
type
immunemedi
xenobioticinduc
hemolysi
classic
caus
amethyldopa
character
predominantli
igg
respons
packman
howev
nucleosid
purin
analog
cladribin
fludarabin
also
associ
hemolysi
due
product
autoimmun
antibodi
garratti
mintzer
et
al
hamblin
third
mechan
xenobiot
may
caus
immunemedi
hemolysi
complex
interact
drug
drug
bind
site
erythrocyt
antibodi
mechan
consid
ternari
complex
mechan
previous
perhap
less
accur
call
immun
complex
innoc
bystand
mechan
packman
quinidin
prototyp
drug
caus
hemolysi
via
mechan
quinidin
may
associ
either
igm
igg
antibodi
predominantli
caus
complementmedi
lysi
erythrocyt
clearanc
complementco
erythrocyt
tissu
macrophag
packman
ceftriaxon
also
report
caus
hemolysi
mechan
arndt
garratti
xenobioticinduc
immunemedi
hemolysi
may
limit
one
three
mechan
describ
earlier
combin
mechan
may
occur
patient
exampl
nsaid
diclofenac
may
caus
hemolysi
drugdepend
drugindepend
mechan
salama
et
al
carboplatin
report
caus
hemolysi
three
immunemedi
mechan
marani
et
al
compound
may
caus
hemolysi
mechan
oxid
microangiopath
immunemedi
exampl
although
primari
effect
lead
toxic
impair
heme
synthesi
lead
may
also
caus
hemolysi
mechan
leadinduc
hemolysi
fulli
determin
interfer
erythrocyt
membran
sodium
potassium
transport
may
involv
bloom
brandt
copper
toxic
caus
hemolysi
well
possibl
inhibit
mani
enzym
involv
glycolysi
result
decreas
intracellular
atp
boulard
et
al
envenom
multipl
anim
report
caus
hemolysi
envenom
snake
rattlesnak
coral
snake
caus
hemolysi
phospholipas
activ
may
caus
direct
hemolysi
liber
hemolysin
lysolethicin
complementmedi
hemolysi
arcebejarano
et
al
tambourgi
van
den
berg
walton
et
al
blood
loss
hemorrhag
hemorrhag
may
caus
intern
extern
blood
loss
due
loss
whole
blood
hemorrhag
decreas
red
cell
mass
usual
accompani
proportion
decreas
albumin
globulin
concentr
decreas
plasma
protein
tend
less
pronounc
intern
hemorrhag
lost
protein
may
resorb
lymph
return
blood
stockham
scott
case
intern
hemorrhag
typic
associ
iron
defici
howev
prolong
extern
blood
loss
may
caus
deplet
total
bodi
iron
iron
defici
anemia
character
small
erythrocyt
decreas
mcv
erythrocyt
contain
less
hemoglobin
decreas
mchc
may
classifi
microcyt
hypochrom
anemia
hemoglobin
synthesi
play
role
inhibit
erythrocyt
divis
suffici
iron
avail
heme
product
loss
inhibitori
effect
result
cell
divis
microcyt
stohlman
et
al
hypochromasia
erythrocyt
due
lower
normal
hemoglobin
content
due
decreas
product
heme
morpholog
erythrocyt
chang
accompani
iron
defici
anemia
includ
visual
microcytosi
hypochromasia
keratocyt
schistocyt
physic
damag
fragil
erythrocyt
sometim
codocyt
also
call
target
cell
thin
rim
pinkstain
hemoglobin
small
central
area
hemoglobin
ring
pallor
typic
erythrocyt
less
hemoglobin
present
rel
amount
membran
chronic
iron
defici
increas
reticulocyt
count
microscop
polychromasia
may
lower
expect
regen
anemia
due
loss
rna
extend
matur
phase
erythrocyt
product
caus
decreas
hemoglobin
content
burkhard
et
al
direct
damag
blood
vessel
trauma
rel
common
caus
acut
extern
intern
blood
loss
traumat
ruptur
spleen
may
also
caus
signific
acut
intern
blood
loss
decreas
red
cell
mass
due
acut
hemorrhag
typic
due
dilut
remain
blood
shift
intracellular
fluid
extracellular
fluid
attempt
preserv
blood
volum
therefor
tissu
perfus
stockham
scott
dilut
red
cell
mass
may
also
observ
follow
administr
intraven
fluid
replac
blood
volum
detect
increas
reticulocyt
count
expect
day
follow
acut
event
patient
normal
function
bone
marrow
damag
blood
vessel
result
hemorrhag
also
may
occur
secondari
ulcer
neoplast
condit
dog
ruptur
splenic
hemangiosarcoma
common
caus
intern
blood
loss
abdomen
hemoabdomen
ulcer
gastrointestin
system
may
lead
blood
loss
fece
observ
black
tarri
fece
melena
ulcer
occur
small
intestin
frank
blood
ulcer
occur
larg
intestin
human
nonhuman
primat
speci
true
menstrual
cycl
includ
old
world
monkey
great
ape
provench
bollig
et
al
decreas
red
cell
mass
uncommon
may
observ
mensesrel
blood
loss
women
heavi
blood
loss
abnorm
cycl
uterin
neoplasm
may
lead
suffici
blood
loss
caus
decreas
red
cell
mass
potenti
even
iron
defici
van
voorhi
goel
gupta
cynomolgu
monkey
decreas
red
cell
mass
occasion
observ
femal
prolong
mens
perigard
et
al
coagul
disord
may
also
associ
either
intern
extern
hemorrhag
primari
defici
coagul
factor
von
willebrand
factor
may
inherit
caus
hemorrhag
defici
coagul
factor
lead
hemorrhag
suffici
caus
decreas
red
cell
mass
includ
hemophilia
factor
viii
defici
hemophilia
b
factor
ix
defici
defici
factor
xi
von
willebrand
factor
usual
mild
often
associ
notabl
hemorrhag
boltonmagg
pasi
hemorrhag
may
secondari
mark
decreas
platelet
count
consumpt
coagulopathi
secondari
infecti
neoplast
process
although
truli
hemorrhag
extern
blood
loss
occur
repeat
phlebotomi
decreas
red
cell
mass
may
acut
observ
follow
collect
blood
donor
transfus
regular
donor
risk
develop
iron
defici
repeat
extern
blood
loss
cabl
et
al
repeat
phlebotomi
common
occurr
nonclin
toxicolog
studi
particularli
dog
nonhuman
primat
although
rat
may
also
occasion
undergo
repeat
blood
collect
blood
collect
studi
mainli
toxicokinet
pharmacokinet
analysi
also
analysi
hematolog
coagul
clinic
chemistri
profil
decreas
red
cell
mass
increas
reticulocyt
count
similar
magnitud
rel
pretest
valu
across
treatment
group
includ
control
common
procedurerel
phenomenon
nonclin
toxicolog
studi
distinguish
true
test
articlerel
effect
parasit
extern
intern
parasit
may
contribut
blood
loss
hookworm
major
intern
parasit
associ
chronic
blood
loss
may
lead
iron
defici
prolong
infect
stoltzfu
et
al
howev
whipworm
infect
schistosomiasi
may
also
associ
blood
loss
latter
associ
blood
loss
urinari
system
farid
et
al
heavi
infest
anim
arthropod
take
blood
meal
tick
lice
flea
may
also
caus
suffici
blood
loss
result
decreas
red
cell
mass
stockham
scott
xenobioticinduc
xenobioticinduc
blood
loss
rel
uncommon
occur
classic
hemorrhag
intestin
tract
result
ulcer
associ
chronic
nsaid
coxib
administr
lain
et
al
langman
et
al
bjarnason
et
al
also
prolong
high
dose
administr
anticoagul
warfarin
heparin
result
hemorrhagerel
decreas
red
cell
mass
levin
et
al
ingest
rodenticid
includ
brodifacoum
chlorophacinon
report
caus
mark
hemorrhag
human
mani
nonrod
speci
berni
et
al
palmer
et
al
sheafor
couto
xenobioticinduc
mark
decreas
platelet
count
may
also
associ
hemorrhag
discuss
detail
later
howev
chemotherapeut
caus
bone
marrow
suppress
associ
spontan
postvenipunctur
hemorrhag
occasion
idiopath
decreas
platelet
count
also
observ
follow
xenobiot
administr
like
attribut
immunemedi
destruct
exampl
implic
xenobiot
quinin
trimethoprimsulfamethoxazol
anticonvuls
phenytoin
carbamazepin
unfraction
low
molecular
weight
heparin
rituximab
aster
bougi
decreas
red
cell
mass
normal
low
reticulocyt
count
nonregen
anemia
depend
time
insult
caus
decreas
red
cell
mass
reticulocyt
count
within
refer
interv
may
repres
preregen
anemia
rather
suppress
erythropoiesi
product
erythrocyt
bone
marrow
requir
least
day
peak
increas
blood
reticulocyt
count
occur
day
follow
insult
stockham
scott
individu
decreas
red
cell
mass
reticulocyt
count
within
refer
interv
unclear
individu
preregen
anemia
suppress
erythropoiesi
repeat
cbc
sever
day
later
may
help
clarifi
process
occur
acut
chaga
diseas
caus
infect
trypanosoma
cruzi
report
caus
decreas
red
cell
mass
human
monkey
de
titto
araujo
rosner
et
al
seah
et
al
experiment
infect
cebu
paella
monkey
acut
phase
chaga
diseas
report
caus
normocyt
normochrom
anemia
rosner
et
al
typic
nonregen
anemia
experiment
infect
mice
demonstr
bone
marrow
suppress
decreas
red
cell
mass
well
decreas
leukocyt
platelet
count
marcond
et
al
although
rare
encount
nonclin
toxicolog
studi
monkey
held
southwestern
unit
state
may
becom
infect
cruzi
prior
distribut
magden
et
al
parasitemia
trypomastigot
may
observ
peripher
blood
smear
viral
infect
may
also
caus
decreas
red
cell
mass
without
concurr
increas
reticulocyt
count
parvovirus
may
caus
decreas
red
cell
mass
direct
infect
erythroid
precursor
result
decreas
erythrocyt
product
well
decreas
erythrocyt
lifespan
parvoviru
may
result
transient
pure
red
cell
aplasia
prca
human
van
horn
et
al
cellmedi
suppress
erythropoiesi
result
prca
also
report
viral
hepat
wilson
et
al
epsteinbarr
viru
infect
socinski
et
al
although
hiv
infect
result
decreas
red
cell
mass
variou
mechan
direct
infect
erythroid
precursor
appear
contribut
suppress
erythropoiesi
evan
scadden
cat
membran
protein
felin
leukemia
viru
associ
decreas
growth
cfue
wellman
et
al
flaviviru
infect
dengu
may
also
result
decreas
red
cell
mass
reticulocyt
count
bone
marrow
suppress
la
russa
inni
anemia
chronic
diseas
acd
rel
common
caus
anemia
anemia
associ
inflammatori
diseas
includ
acd
decreas
red
cell
mass
observ
acd
gener
mild
gener
normocyt
normochrom
indic
chang
mcv
mchc
respect
acd
may
occur
shorten
erythrocyt
lifespan
alter
iron
metabol
blunt
respons
erythroid
precursor
epo
decreas
epo
product
alter
erythrocyt
lifespan
patient
acd
may
relat
increas
macrophag
clearanc
erythrocyt
circul
unknown
mechan
ganz
type
mechan
associ
sever
chronic
infect
includ
tuberculosi
endocard
weiss
commonli
acd
associ
impair
iron
mobil
low
iron
concentr
serum
plasma
despit
adequ
iron
store
mean
impair
mobil
iron
result
induct
hepcidin
result
sequestr
iron
macrophag
decreas
intestin
iron
updat
ganz
stimul
increas
synthesi
ferritin
may
bind
iron
impair
deliveri
iron
erythroid
precursor
roger
et
al
decreas
express
impair
intern
transferrin
receptor
mean
acd
impair
iron
metabol
associ
numer
inflammatori
infecti
even
neoplast
condit
acd
may
also
caus
alter
epo
respons
decreas
epo
product
decreas
respons
erythroid
precursor
epo
cytokinemedi
associ
increas
tnfa
interferon
johnson
et
al
johnson
et
al
raefski
et
al
may
commonli
associ
inflammatori
condit
decreas
epo
product
may
also
cytokinemedi
report
increas
tgfb
tnfa
faquin
et
al
jelkmann
et
al
howev
chronic
renal
diseas
may
also
result
directli
impair
epo
product
decreas
product
erythrocyt
sato
yanagita
immunemedi
destruct
erythroid
precursor
bone
marrow
result
decreas
red
cell
mass
concurr
decreas
reticulocyt
count
immunemedi
condit
discuss
may
repres
spectrum
diseas
associ
immun
destruct
variou
stage
erythroid
precursor
rather
unrel
entiti
autoimmun
hemolyt
anemia
decreas
reticulocyt
count
autoimmun
hemolyt
anemia
antibodi
target
antigen
midto
latestag
erythroid
precursor
rang
rubricyt
metarubricyt
result
aiha
decreas
reticulocyt
count
may
also
call
immunemedi
nonregen
anemia
precursortarget
immunemedi
anemia
pima
aiha
reticulocytopenia
gener
normocyt
normochrom
anemia
bone
marrow
examin
may
reveal
erythroid
hyperplasia
matur
arrest
weiss
pyramid
expans
erythroid
precursor
stage
earlier
target
stage
indic
ineffect
erythropoiesi
may
less
appar
autoantibodi
recogn
immatur
stage
erythroid
precursor
bone
marrow
evalu
may
also
reveal
rubriphagocytosi
erythroid
precursor
phagocyt
macrophag
stage
phagocyt
precursor
depend
stage
stage
express
target
antigen
pure
red
cell
aplasia
patient
affect
prca
mark
decreas
reticulocyt
count
along
variabl
decreas
red
cell
mass
bone
marrow
examin
typic
reveal
absenc
erythroid
precursor
erythroid
aplasia
low
number
earliest
stage
erythroid
precursor
erythroid
hypoplasia
young
prca
peopl
may
caus
antibodi
bind
antigen
earliest
erythroid
precursor
even
antibodi
bind
epo
prevent
epodepend
erythropoiesi
also
attribut
clonal
tcell
disord
stockham
scott
prca
dog
associ
igg
inhibit
erythropoiesi
weiss
prca
may
also
caus
inherit
genet
defect
peopl
inherit
prca
peopl
call
diamondblackfan
anemia
often
autosom
domin
inherit
pattern
defect
gene
encod
ribosom
protein
young
macrocytosi
increas
number
larg
erythrocyt
increas
mcv
may
observ
consist
impair
epodepend
erythropoiesi
young
oheneabuakwa
et
al
aplast
anemia
aplast
anemia
condit
associ
decreas
cellular
blood
compon
pancytopenia
includ
decreas
red
cell
mass
concurr
decreas
reticulocyt
count
upon
examin
bone
marrow
classic
sever
hypocellular
hematopoiet
cell
absenc
hematopoiet
precursor
marrow
caviti
fill
mostli
adipocyt
stromal
element
aplast
anemia
thought
commonli
immunemedi
young
et
al
may
frequent
associ
cytotox
tcell
becom
autoreact
segel
lichtman
howev
also
case
inherit
aplast
anemia
commonli
fanconi
anemia
associ
genet
mutat
impair
dna
repair
result
pancytopenia
develop
around
year
age
peopl
segel
lichtman
form
aplast
anemia
associ
bone
marrow
deplet
hypocellular
hematopoiet
tissu
gelatin
transform
marrow
caviti
fat
report
anorexia
nervosa
peopl
abella
et
al
sever
food
restrict
rat
moriyama
et
al
nutrit
defici
addit
aplast
anemia
associ
anorexia
nervosa
sever
food
restrict
nutrit
defici
associ
ineffect
erythropoiesi
lead
decreas
red
cell
mass
decreas
reticulocyt
count
iron
defici
defici
b
vitamin
folat
cobalamin
exampl
nutrit
defici
chronic
iron
defici
result
impair
hematopoiesi
due
inabl
synthes
suffici
hemoglobin
may
lead
decreas
reticulocyt
product
defici
folat
cobalamin
also
caus
ineffect
erythropoiesi
due
defect
dna
synthesi
discuss
folat
cobalamin
defici
caus
deceas
neutrophil
count
peopl
folat
cobalamin
defici
result
megaloblast
anemia
character
larger
normal
erythroid
precursor
bone
marrow
cytoplasm
lower
nuclear
cytoplasm
ratio
normal
erythroid
precursor
asynchron
cytoplasm
nuclear
matur
green
megaloblast
erythrocyt
may
also
observ
circul
basophil
stippl
howelljolli
bodi
may
also
observ
green
peopl
anemia
attribut
defici
cobalamin
vitamin
b
may
also
call
pernici
anemia
dog
cat
megaloblast
erythroid
cell
may
observ
bone
marrow
may
observ
blood
stockham
scott
sever
endocrinopathi
also
associ
decreas
red
cell
mass
decreas
reticulocyt
count
includ
hypothyroid
hypoadrenocortic
hyperestrogen
case
hypothyroid
sever
mechan
may
contribut
decreas
red
cell
mass
decreas
folat
cobalamin
concentr
secondari
hypothyroid
lead
ineffect
erythropoiesi
decreas
tissu
oxygen
demand
lead
decreas
epo
lower
baselin
red
cell
mass
acd
may
contribut
mild
decreas
red
cell
mass
observ
hypothyroid
ottesen
et
al
hine
et
al
stockham
scott
mehmet
et
al
mild
decreas
red
cell
mass
without
appar
chang
reticulocyt
count
associ
hypoadrenocortic
may
due
decreas
glucocorticoid
loss
appar
proerythropoiet
stimul
glucocorticoid
stockham
scott
hyperestrogen
occur
ovarian
testicular
neoplasm
may
result
bone
marrow
toxic
suppress
erythropoiesi
particularli
dog
sonta
et
al
neoplasia
may
result
suppress
erythropoiesi
may
due
neoplasiarel
inflamm
cytokin
releas
lead
acd
howev
granulocyt
leukemia
lymphoprolif
neoplasia
involv
bone
marrow
may
result
crowd
effac
bone
marrow
caviti
impair
erythropoiesi
result
decreas
red
cell
mass
concurr
decreas
reticulocyt
count
hematopoiet
neoplasia
involv
erythroid
lineag
usual
result
atyp
erythrocyt
product
lead
decreas
red
cell
mass
reticulocyt
count
howev
nucleat
erythrocyt
evid
dysplasia
may
observ
blood
similar
hematopoiet
neoplasm
effac
bone
marrow
metastat
neoplasia
often
carcinoma
may
also
caus
myelophthisi
result
decreas
erythropoiesi
mani
xenobiot
caus
decreas
red
cell
mass
concurr
decreas
reticulocyt
count
bone
marrow
suppress
affect
erythroid
lineag
commonli
observ
chemotherapeut
gener
exampl
agent
directli
cytotox
hematopoiet
precursor
inhibit
mitot
spindl
format
antimetabolit
alter
folat
metabol
may
result
suppress
erythropoiesi
howev
develop
parvovirusinduc
prca
report
consequ
chemotherapeut
administr
song
et
al
rao
et
al
prca
occasion
link
xenobiot
treatment
wide
varieti
xenobiot
mani
differ
class
report
caus
prca
exampl
xenobiot
reportedli
associ
pcra
includ
sulfonamid
allopurinol
procainamid
goldcontain
compound
rifampin
chloroquin
young
mintzer
et
al
howev
causal
often
difficult
prove
associ
limit
low
number
case
report
one
studi
evalu
report
prca
associ
administr
differ
xenobiot
causal
attribut
treatment
azathioprin
isoniazid
phenytoin
thompson
gale
prca
due
develop
antiepo
antibodi
may
follow
administr
recombin
epo
human
casadeval
et
al
epo
gene
therapi
monkey
gao
et
al
administr
recombin
epo
dog
also
led
develop
antiepo
antibodi
prca
randolph
et
al
aplast
anemia
also
link
administr
xenobiot
classic
chloramphenicol
report
sporad
caus
aplast
anemia
segel
lichtman
howev
antithyroid
compound
sulfonamid
includ
trimethoprim
sulfamethoxazol
betalactam
diuret
furosemid
goldcontain
compound
penicillamin
anticonvuls
includ
carbamazepin
phenacetin
report
associ
aplast
anemia
mintzer
et
al
kaufman
et
al
aplast
anemia
also
attribut
environment
occup
exposur
benzen
smith
case
aplast
anemia
dog
griseofulvin
administr
suspect
caus
aplast
anemia
brazzel
weiss
decreas
red
cell
mass
concurr
decreas
reticulocyt
count
occur
prolong
repeat
high
dose
administr
gcsf
gmcsfbase
xenobiot
nonclin
toxicolog
studi
particularli
rodent
impair
erythropoiesi
case
occur
due
massiv
expans
myeloid
precursor
within
bone
marrow
extrem
myeloid
hyperplasia
continu
stimul
result
overcrowd
marrow
caviti
less
physic
space
avail
erythroid
product
product
platelet
megakaryocyt
thrombopoiesi
product
megakaryocyt
megakaryopoiesi
occur
mainli
bone
marrow
adult
anim
common
myeloid
progenitor
differenti
megakaryocyteerythroid
progenitor
differenti
result
format
earliest
commit
megakaryocyt
cell
burstform
unitmegakaryocyt
bfumk
differenti
colonyform
unitmegakaryocyt
cfumk
subsequ
stage
differenti
megakaryoblast
follow
promegakaryocyt
megakaryocyt
latter
stage
may
recogn
light
microscop
evalu
bone
marrow
extens
megakaryocyt
cytoplasm
proplatelet
enter
sinus
microvasculatur
bone
marrow
within
sinus
proplatelet
detach
megakaryocyt
shear
forc
blood
fragment
platelet
harvey
junt
et
al
thrombopoiesi
well
megakaryopoiesi
predominantli
stimul
tpo
howev
scf
stromal
cellderiv
factor
gcsf
gmcsf
may
contribut
platelet
product
boudreaux
larg
speciesbas
variat
platelet
count
health
rodent
gener
highest
platelet
count
common
laboratori
speci
may
exceed
platelet
ml
nonhuman
primat
dog
gener
lower
highli
variabl
platelet
count
circul
lifespan
platelet
approxim
day
circul
platelet
may
transient
contain
spleen
russel
clearanc
senesc
platelet
circul
mainli
due
phagocytosi
splenic
macrophag
catecholamineinduc
increas
circul
catecholamin
concentr
epinephrin
fright
excit
result
mobil
platelet
spleen
circul
usual
splenic
contract
increas
platelet
count
catecholamineinduc
redistribut
gener
transient
resolv
splenic
relax
decreas
catecholamin
concentr
back
basal
level
strenuou
exercis
may
also
caus
redistribut
splenic
platelet
due
aadrenerg
stimul
result
increas
blood
platelet
count
chamberlain
et
al
inflammatori
reactiv
increas
platelet
count
typic
secondari
process
caus
gener
bone
marrow
stimul
result
increas
circul
tpo
therefor
increas
thrombopoiesi
increas
platelet
clonal
increas
may
occur
result
inflammatori
immun
stimul
myriad
etiolog
may
also
increas
part
paraneoplast
syndrom
associ
malign
neoplasia
nonhem
origin
includ
renal
cell
carcinoma
ovarian
neoplasia
primari
lung
cancer
gastrointestin
neoplasia
blay
et
al
stone
et
al
yanagawa
et
al
kabir
et
al
lin
et
al
increas
concentr
demonstr
increas
liver
product
tpo
kaser
et
al
stimul
thrombopoiesi
consequ
increas
blood
platelet
count
iron
defici
decreas
red
cell
mass
associ
reactiv
increas
platelet
count
mani
case
stockham
scott
mechan
increas
platelet
count
unclear
dan
studi
demonstr
detect
increas
tpo
iron
defici
anemia
akan
et
al
although
epo
increas
iron
defici
anemia
crossreact
tpo
epo
explain
reactiv
thrombocytosi
geddi
kaushanski
transient
increas
blood
platelet
count
report
follow
splenectomi
splenectomi
associ
increas
circul
tpo
level
ichikawa
et
al
result
increas
platelet
product
ion
observ
increas
platelet
count
increas
tpo
also
occur
instanc
decreas
platelet
count
observ
immunemedi
platelet
destruct
bone
marrow
suppress
blood
loss
discuss
later
follow
resolut
caus
decreas
blood
platelet
count
tpo
stimul
increas
product
may
caus
transient
increas
blood
platelet
count
rebound
thrombocytosi
prior
normal
platelet
count
stockham
scott
neoplast
process
caus
primari
nonreact
increas
blood
platelet
count
character
clonal
expans
megakaryocyt
therefor
platelet
hemic
neoplasia
may
result
clonal
increas
platelet
count
includ
acut
megakaryoblast
leukemia
chronic
myeloprolif
diseas
primari
essenti
thrombocythemia
howev
clonal
increas
platelet
count
associ
increas
tpo
greater
increas
tpo
observ
reactiv
thrombocytosi
tpomedi
thrombopoiesi
may
also
play
role
clonal
increas
platelet
count
wang
et
al
acut
megakaryoblast
leukemia
aml
bone
marrow
contain
megakaryoblast
mani
cell
megakaryocyt
lineag
cytoplasm
bleb
gassmann
myelofibrosi
frequent
also
observ
tallman
et
al
acut
megakaryoblast
leukemia
associ
increas
platelet
count
decreas
platelet
count
also
describ
stockham
scott
major
case
acut
megakaryoblast
leukemia
adult
children
associ
chromosom
abnorm
often
chromosom
transloc
duchayn
et
al
lion
et
al
primari
thrombocythemia
associ
mark
increas
platelet
count
bone
marrow
megakaryoblast
contrast
acut
megakaryoblast
leukemia
evid
platelet
dysplasia
may
observ
microscop
evalu
blood
smear
morpholog
chang
may
includ
hypogranular
platelet
larg
platelet
associ
increas
mean
platelet
volum
mpv
pleomorph
platelet
stockham
scott
similar
polycythemia
vera
primari
thrombocythemia
associ
activ
mutat
levin
et
al
howev
primari
thrombocythemia
may
also
associ
mutat
tpo
receptor
gene
mpl
calreticulin
gene
calr
beer
green
administr
exogen
catecholamin
report
caus
increas
blood
platelet
count
mechan
primarili
splenic
contract
transient
increas
platelet
count
howev
platelet
pool
pulmonari
circul
may
also
contribut
exampl
administr
epinephrin
dog
result
doserespons
increas
blood
platelet
count
believ
result
adrenalineinduc
mobil
platelet
pulmonari
circul
peripher
blood
bierman
et
al
increas
platelet
count
associ
xenobiot
administr
commonli
reactiv
associ
increas
andor
tpo
xenobiot
result
inflammatori
stimulu
may
result
reactiv
increas
platelet
count
exampl
xenobiot
discuss
detail
previou
section
resolut
xenobioticinduc
bone
marrow
suppress
may
caus
transient
rebound
increas
platelet
count
due
increas
tpo
thrombopoiesi
secondari
xenobioticinduc
decreas
platelet
count
gcsf
gmcsfbase
xenobiot
administr
associ
increas
blood
platelet
count
gener
bone
marrow
stimul
chang
may
due
prolifer
myeloid
precursor
includ
common
precursor
may
differenti
megakaryocyt
xenobioticinduc
increas
platelet
count
also
attribut
treatment
vinca
alkaloid
miconazol
believ
attribut
abil
xenobiot
stimul
increas
megakaryocyt
product
within
bone
marrow
frye
thompson
increas
platelet
count
report
treatment
sever
antibiot
class
includ
cephalosporin
blactam
penicillin
causal
difficult
prove
case
reactiv
thrombocytosi
inflamm
associ
infecti
process
treat
must
consid
frye
thompson
mark
decreas
platelet
count
clinic
concern
may
associ
spontan
bleed
anim
typic
consid
risk
spontan
bleed
platelet
count
ml
significantli
greater
risk
spontan
bleed
platelet
ml
russel
although
hemorrhag
platelet
count
ml
may
also
occur
follow
surgeri
trauma
includ
venipunctur
routin
perform
nonclin
toxicolog
studi
minim
moder
decreas
platelet
count
typic
associ
hemorrhag
major
clinic
concern
unless
concurr
platelet
function
defect
increas
mpv
indic
increas
averag
platelet
size
may
associ
rapid
increas
thrombopoiesi
indic
bone
marrow
respons
decreas
platelet
count
rel
decreas
platelet
count
occur
circul
platelet
mass
chang
platelet
clump
redistribut
hemodilut
alter
autom
estim
platelet
count
fals
decreas
platelet
count
pseudothrombocytopenia
due
platelet
clump
often
present
rat
mice
cat
although
may
observ
speci
mpv
may
increas
presenc
platelet
clump
microscop
blood
smear
review
perform
case
decreas
platelet
count
assess
presenc
platelet
clump
increas
mpv
instanc
platelet
clump
reflect
bone
marrow
respons
true
decreas
platelet
count
present
stimul
thrombopoiesi
resampl
blood
clean
venipunctur
use
sodium
citrat
anticoagul
may
help
reduc
platelet
clump
result
accur
autom
platelet
count
redistribut
sequestr
circul
platelet
may
caus
decreas
platelet
count
may
transient
platelet
redistribut
may
observ
splenomegali
hypersplen
sever
hypothermia
total
platelet
mass
unaffect
case
typic
result
increas
tpo
platelet
product
stockham
scott
hemodilut
may
occur
follow
administr
intraven
fluid
massiv
transfus
expect
decreas
blood
compon
variabl
degre
except
transfus
blood
compon
decreas
platelet
hemodilut
usual
mild
may
detect
platelet
count
remain
within
refer
interv
histor
control
rang
chang
gener
transient
resolv
redistribut
intravascular
extracellular
fluid
intracellular
fluid
compart
elimin
excess
fluid
acut
sever
loss
whole
blood
may
result
decreas
blood
compon
includ
platelet
blood
loss
signific
magnitud
caus
decreas
blood
platelet
count
may
occur
follow
trauma
splenic
ruptur
trauma
neoplasia
uncontrol
bleed
associ
coagulopathi
hemophilia
b
howev
consumpt
platelet
site
hemorrhag
may
also
contribut
decreas
platelet
count
observ
blood
loss
decreas
platelet
surviv
may
due
increas
platelet
destruct
andor
consumpt
rel
common
caus
decreas
blood
platelet
count
destruct
platelet
commonli
associ
immunemedi
mechan
includ
immunemedi
thrombocytopenia
imt
immunemedi
thrombocytopen
purpura
itp
human
autoantibodi
caus
platelet
destruct
igg
class
although
case
igm
iga
antiplatelet
antibodi
also
report
antiplatelet
antibodi
may
directli
target
platelet
antigen
glycoprotein
integrin
iib
b
gpiibiiia
play
major
role
platelet
aggreg
et
al
antigen
expos
form
platelet
surfac
infecti
agent
infecti
agenttarget
antibodi
crossreact
normal
express
platelet
surfac
antigen
membran
compon
phospholipid
stockham
scott
antibodybound
platelet
may
phagocytos
destroy
splenic
bone
marrow
hepat
macrophag
may
associ
complementmedi
destruct
stimul
phagocytosi
russel
product
antiplatelet
antibodi
may
unassoci
underli
diseas
condit
idiopath
primari
usual
presum
autoimmun
process
may
secondari
infecti
neoplast
process
stockham
scott
sexual
matur
minipig
spontan
thrombocytopen
purpura
describ
believ
caus
immunemedi
platelet
destruct
carrasco
et
al
itp
secondari
infecti
diseas
report
occur
variou
bacteri
viral
etiolog
includ
helicobact
pylori
mani
rickettsi
diseas
hiv
cytomegaloviru
hepat
b
c
virus
russel
cine
et
al
lymphoprolif
neoplasia
rel
common
caus
itp
associ
chronic
lymphocyt
leukemia
hodgkin
lymphoma
leukemia
larg
granular
tlymphocyt
cine
et
al
connect
tissu
diseas
sle
also
associ
itp
cine
et
al
decreas
platelet
count
due
platelet
activ
consumpt
commonli
associ
local
dissemin
consumpt
coagulopathi
local
consumpt
coagulopathi
may
associ
site
hemorrhag
microangiopathi
thrombosi
vascular
neoplasia
hemangiosarcoma
stockham
scott
thrombosi
associ
chronic
catheter
may
caus
local
platelet
consumpt
dic
may
associ
infecti
agent
particularli
bacteri
infect
caus
septicemia
endotoxemia
hepat
diseas
varieti
neoplast
diseas
pancreat
stockham
scott
activ
consumpt
platelet
associ
decreas
platelet
count
also
observ
vascul
condit
associ
turbul
blood
flow
endocard
cardiac
valvular
diseas
follow
cardiac
surgeri
arteri
diseas
alter
damag
endotheli
cell
russel
selleng
et
al
stockham
scott
gregg
goldschmidtclermont
hemolyt
urem
syndrom
hu
caus
thrombot
microangiopathi
may
associ
infect
shigella
dysenteria
escherichia
coli
russel
bone
marrow
suppress
involv
megakaryocyt
lineag
caus
decreas
platelet
product
therefor
decreas
platelet
count
bone
marrow
suppress
may
occur
associ
infecti
agent
directli
infect
hematopoiet
precursor
immunodefici
virus
variou
speci
parvovirus
distemp
viru
dog
felin
leukemia
viru
cat
russel
stockham
scott
scaradav
chronic
ehrlichiosi
dog
also
report
caus
bone
marrow
hypoplasia
although
mechan
remain
unclear
stockham
scott
howev
decreas
platelet
count
attribut
infecti
agent
may
contribut
mechan
bone
marrow
suppress
peripher
consumpt
immunemedi
destruct
hyperestrogen
associ
testicular
ovarian
neoplasia
may
also
caus
gener
bone
marrow
suppress
dog
appear
particularli
sensit
effect
sonta
et
al
caus
decreas
bone
marrow
megakaryocyt
decreas
blood
platelet
count
also
associ
mechan
like
immunemedi
aplast
anemia
commonli
caus
immunemedi
mechan
young
et
al
associ
gener
bone
marrow
hypoplasia
involv
hematopoiet
lineag
includ
megakaryocyt
amegakaryocyt
thrombocytopen
purpura
human
may
inherit
acquir
acquir
form
commonli
occur
immunemedi
mechan
inherit
congenit
form
caus
mark
decreas
blood
platelet
count
absenc
megakaryocyt
bone
marrow
form
frequent
associ
mutat
tpo
receptor
gene
mpl
may
progress
aplast
anemia
germeshausen
et
al
van
den
oudenrijn
et
al
acquir
amegakaryocyt
thrombocytopen
purpura
like
associ
immunemedi
decreas
bone
marrow
megakaryocyt
tristano
antibodi
bind
tpo
tpo
receptor
also
report
caus
acquir
amegakaryocyt
thrombocytopen
purpura
shiozaki
et
al
katsumata
et
al
gener
bone
marrow
diseas
replac
normal
bone
marrow
hematopoiet
tissu
hemic
nonhem
neoplasia
sever
granulomat
inflamm
effac
normal
bone
marrow
tissu
myelofibrosi
bone
marrow
necrosi
result
decreas
megakaryocyt
thrombopoiesi
subsequ
decreas
blood
platelet
count
russel
stockham
scott
blood
loss
associ
xenobiot
report
coagulopathi
due
abnorm
vitamin
k
recycl
function
vitamin
kdepend
coagul
factor
drug
implic
abnorm
vitamin
k
synthesi
includ
warfarin
rodenticid
brodifacoum
broadspectrum
antibiot
bloom
brandt
sever
acut
loss
whole
blood
blood
compon
includ
platelet
decreas
mechan
xenobioticinduc
decreas
platelet
count
discuss
later
caus
sever
enough
decreas
blood
platelet
count
eg
platelet
ml
blood
loss
could
secondari
decreas
platelet
thrombot
microangiopathi
syndrom
may
includ
thrombot
thrombocytopen
purpura
ttp
hu
may
caus
peripher
consumpt
andor
destruct
platelet
develop
decreas
platelet
count
xenobioticinduc
endotheli
injuri
lead
platelet
activ
aggreg
pisoni
et
al
sever
chemotherapeut
agent
associ
thrombot
microangiopathi
syndrom
includ
mitomycin
c
cantrel
et
al
cisplatin
palmisano
et
al
estramustin
phosphat
tassinari
et
al
gemcitabin
nackaert
et
al
daunorubicin
byrn
et
al
nonchemotherapeut
agent
includ
immunomodul
cyclosporin
tacrolimu
katznelson
et
al
trimarchi
et
al
simvastatin
mccarthi
et
al
inhibitor
platelet
aggreg
includ
ticlopidin
clopidogrel
bennett
et
al
also
associ
thrombot
microangiopathi
syndrom
immunemedi
destruct
platelet
rel
common
caus
xenobioticinduc
decreas
blood
platelet
count
antiplatelet
antibodi
may
form
variou
mechan
penicillin
cephalosporin
caus
platelet
destruct
haptentyp
drugdepend
antibodi
product
quinidin
nsaid
caus
immunemedi
platelet
destruct
format
antibodi
bind
platelet
solubl
drug
present
aster
bougi
drug
inhibit
platelet
glycoprotein
iib
b
gpiibiiia
may
lead
platelet
express
new
antigen
due
conform
chang
glycoprotein
complex
bound
antibodi
drug
includ
tirofiban
roxifiban
eptifibatid
aster
bougi
aster
abciximab
report
caus
drugspecif
antibodi
caus
decreas
platelet
count
aster
xenobioticinduc
product
autoantibodi
bind
platelet
drugindepend
antibodi
attribut
procainamid
goldbas
compound
administr
aster
bougi
human
immunecomplex
type
antibodi
classic
associ
heparin
therapi
due
interact
heparin
platelet
granul
compon
platelet
factor
aster
bougi
visentin
liu
arep
ortel
bone
marrow
suppress
caus
numer
xenobiot
notabl
chemotherapeut
agent
chemotherapeut
agent
associ
bone
marrow
suppress
includ
compound
mani
class
includ
alkyl
agent
busulfan
antimetabolit
impair
dna
synthesi
methotrex
mercaptopurin
antibiot
doxorubicin
mitot
spindl
inhibitor
vinca
alkaloid
vinblastin
vincristin
carey
weiss
stockham
scott
idiosyncrat
myelosuppress
may
also
occur
numer
nonchemotherapeut
xenobiot
report
antithyroid
drug
methimazol
anticonvuls
includ
felbam
carbamazepin
antipsychot
agent
clozapin
cardiovascular
drug
methyldopa
captopril
antibiot
includ
trimethoprimsulfamethoxazol
chloroquin
xenobiot
agent
includ
goldbas
compound
diclofenac
allopurinol
carey
xenobioticinduc
aplast
anemia
commonli
associ
immunemedi
destruct
uncommit
earli
hematopoiet
stem
cell
although
direct
cytotox
chemotherapeut
agent
may
also
lead
aplast
anemia
sever
xenobiot
includ
chloramphenicol
anticonvuls
phenytoin
carbamazepin
goldbas
compound
phenylbutazon
associ
aplast
anemia
bloom
brandt
miscellan
caus
xenobioticinduc
decreas
blood
platelet
count
includ
nonimmunemedi
destruct
report
occur
desmopressin
bloom
brandt
idiosyncrat
reaction
associ
carpa
szebeni
administr
antisens
oligonucleotid
frazier
idiosyncrat
decreas
platelet
count
also
report
offtarget
effect
human
monoclon
antibodi
nonclin
toxicolog
studi
everd
et
al
numer
caus
direct
alter
blood
compon
includ
increas
number
xenobiot
alter
bone
marrow
hematopoiet
system
either
independ
xenobiot
induc
xenobiot
may
also
result
chang
peripher
blood
cell
count
mani
mechan
alter
blood
cell
count
relat
xenobiot
administr
consider
overlap
mechan
xenobiot
caus
chang
understand
mechan
associ
individu
compound
drug
class
may
help
elucid
potenti
pathway
novel
xenobiot
caus
alter
blood
compon
